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Cancer is a complex chronic disease that has remained a paramount public health problem for the 
last 42 years. Systemic treatments, like chemotherapy, or local therapies, like radiation, are often 
used to treat metastatic cancer. Chemotherapy and radiation can cause a host of physical side 
effects including fatigue, hair loss, nausea, and vomiting. To combat these side effects of 
treatment, cancer patients and survivors turn to complementary and alternative medicine (CAM) 
both during and after cancer treatment, to improve their prognosis, symptoms, and quality of life.  
While CAM is often sought for symptom abatement, many patients fail to disclose their 
CAM use to their healthcare providers, despite the potential for adverse reactions with 
conventional treatments. To understand issues associated with CAM use, including the 
nondisclosure patterns, the National Cancer Institute Office of Cancer Complementary and 
Alternative Medicine’s (OCCAM) existing sources of qualitative data were reviewed along with 
the websites of several national cancer advocacy groups. A literature search on the motivations 
for CAM use and the barriers and facilitators to patient-provider communication about CAM was 
conducted to understand the current research on communication about CAM in different 
healthcare settings.  
Under the auspices of OCCAM, the author developed an interactive workbook to 
encourage patients’ participation in their health care by increasing their confidence to talk to 
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their providers about CAM. The workbook contains different adaptations of health diaries to help 
patients track their motivations for CAM use, the frequency of their CAM use, and all of their 
medications, including vitamins, herbs, and dietary supplements. Two rounds of pretesting with 
cancer survivors and healthcare providers were conducted to determine the usability and 
functionality of the workbook. The healthcare providers and cancer survivors surveyed believed 
OCCAM’s initiative is an important resource because it empowers patients to help their 
healthcare providers understand their coping mechanisms during and after cancer care, including 
their use of CAM. This initiative has public health significance because there are limited patient 
education resources that encourage patients to talk to their providers about CAM and 
furthermore, when patients and providers communicate with each other, patients experience 
more positive health outcomes.  
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From January 9, 2012, through November 14, 2012, I participated in the National Cancer 
Institute’s Health Communications Internship Program (HCIP). Typically, the Health 
Communications Internship Program (HCIP) is a six-month to one-year internship sponsored by 
the National Cancer Institute (NCI). This internship program provides current graduate students 
and recent graduates with the opportunity to participate in a health communications or scientific 
writing internship at one of the offices, centers, or divisions of the National Cancer Institute. 
Students who participate in the HCIP program develop initiatives that increase the NCI’s 
dissemination of cancer information to the American public. As an HCIP intern, I was placed in 
the Office of Cancer Complementary and Alternative Medicine (OCCAM) and was specifically 
assigned to work in the Communications and Outreach Program (COP).  
OCCAM is one of the offices that support the overall mission of the National Cancer 
Institute, “to conduct and support research, training, health information dissemination, and other 
programs with respect to the cause, diagnosis, prevention, and treatment of cancer, rehabilitation 
from cancer, and the continuing care of cancer patients and the families of cancer patients,”1 by 
studying the role of complementary and alternative medicine (CAM) in cancer. OCCAM 
accomplishes these ends through its various programs, including the Office of the Director, the 
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Communications and Outreach Program, the Case Review and Intramural Science Program, the 
Extramural Research Program, and the Research Development and Support Program.  
During the first month of the internship, I had several meetings with each of the program 
directors of OCCAM, including the office director, Dr. Jeffrey D. White, to learn about the 
various projects and tasks conducted within the office. By the end of January, I was provided an 
explanation of my internship-specific project. I was tasked with developing a patient education 
resource to not only increase OCCAM’s patient education portfolio, but more importantly to 
increase knowledge about cancer CAM. Both the communication medium and topic were left 
undefined; however, through the design process, I was asked to determine the best methods of 
communicating cancer CAM information to patients.  
This project would not have been completed without the support of Dr. Jeffrey D. White, 
Elizabeth Austin, Barbara McMakin, and the rest of OCCAM’s staff. I appreciate the confidence 
and trust you placed in me to take on the role of project lead for this communication initiative. I 
cannot thank you enough for supporting my growth as a burgeoning public health professional, 
encouraging my attendance to various lectures, seminars, trainings, and classes, and offering 
career advice throughout the entire course of my internship.  
I would also like to express sincere gratitude to Shea Buckman Manley without whom 
much of the outreach efforts and feedback obtained would not have occurred. Lastly, I would 
like to thank the Health Communications Internship Program staff, Katie Fontaine, Isabel 
Valencia, and Teresa Estrada for coordinating the program and encouraging the 2012 intern class 
to pursue as many opportunities at the National Institutes of Health (NIH) as possible. 
My sincere gratitude also extends to my various academic mentors at the Graduate 
School of Public Health, especially Dr. Martha Ann Terry for her guidance, encouragement, and 
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mentorship throughout my entire time at the Graduate School of Public Health. I’d also like to 
thank Dr. Elizabeth Felter and Dr. Tammy Haley for their critiques and support of my work, 
encouraging me every step of the way through the development of my master’s thesis. I’d also 
like to express my gratitude toward Dr. Beth Nolan for her continued mentorship and support of 
all of my personal and professional endeavors.   
To all of the friends who entered my life at various points in time, whether as childhood 
friends, undergraduate students, masters students, coworkers, or fellow HCIP interns, thank you 
for your friendship, laughter, and support of both this project and me. 
Finally, I’d like to thank my family for their unconditional love and encouragement. To 
my grandparents, Greta (deceased) and Melvin Schissler, thank you for always believing in my 
capabilities and insisting I pursue higher education. To my parents, Michael and Karen Golya, I 
will be forever grateful for your unwavering support of my academic, professional, and personal 
pursuits. You have always believed and will continue to believe in my ability to accomplish 
anything I set my mind to, even when I am plagued with self-doubt. Thank you for encouraging 
me to chase after my dreams and for being there every step of the way as I inch closer and closer 
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1.0  INTRODUCTION 
Cancer is a chronic health problem that has remained a paramount national health priority since 
1971, when President Nixon declared “the conquest on cancer” by signing the National Cancer 
Act of 1971.2 Forty-two years later, cancer continues to be a devastating disease that affects 
people of all races, sexes, and ages; cancer is the second leading cause of death of Americans, 
preceded only by heart disease.3 National trends indicate that the overall cancer death rates for 
several of the leading cancer types, (lung, prostate, colorectal, breast (women), ovary, brain, 
kidney, stomach, oral cavity, larynx (men), leukemia, non-Hodgkin’s lymphoma, myeloma, 
bladder (women), esophagus (women), and gallbladder (women)) have declined over the past 
two decades for men and women of all races and ethnicities.4 However, while the mortality rates 
and incidences of the aforementioned cancers continue to decline, the incidence of several other 
cancer types, namely pancreas, liver (men), melanoma (men), and uterus (women) have begun to 
increase.4 Even with the death rates of some of the leading types of cancer declining, cancer 
continues to plague the health of the nation and directly influences healthcare costs. In 2012, it 
was estimated 1,638,910 new cases of cancer would be diagnosed and 577,190 Americans would 
die from cancer.3 In 2010, the national costs for cancer care were $124 billion dollars and the 
cancer costs are projected to increase to $158 billion (in 2010 dollars) by 2020.5  
An important component in cancer care and a direct contributor to associated medical 
costs is deciding on the best course of action to combat cancer. Some of the standard 
 2 
conventional treatments include, but are not limited to, chemotherapy, radiation, surgery, 
targeted therapy, and stem cell transplants. The choice of therapy is influenced by multiple 
factors, including but not limited to the stage of diagnosis, cancer site, and patient preference. 
Each therapy is associated with a set of risks and benefits that patients, their families, and their 
healthcare providers must openly discuss. Treatment protocol conversations should also include 
discussions of possible side effects and complications from treatment, such as the physical and 
mental side effects of chemotherapy and radiation. Frequently observed symptoms during the 
administration of chemotherapy or radiation include anemia (chemotherapy), diarrhea, fatigue, 
hair loss, mouth changes, nausea and vomiting, nerve and muscle changes (chemotherapy), skin 
changes, and increased chance of bruising, bleeding, and infection (chemotherapy).6,7  Typically, 
the symptoms that occur in the active phases of treatment are the most severe, however, many 
late effects of cancer treatments may also persist among cancer survivors, including fatigue, 
insomnia, neuropathy, and pain.8 
To combat these side effects, some cancer patients and survivors turn to complementary 
and alternative medicine (CAM) to lessen the severity of symptoms. The Office of Cancer 
Complementary and Alternative Medicine (OCCAM) defines complementary and alternative 
medicine as “any medical system, practice, or product that is not thought of as standard care.”9 
CAM is typically organized into five categories which include alternative medical systems, 
energy therapies, manipulative and body-based methods, mind-body interventions, and 
nutritional theraupeutics.9 Examples of modalities within each of the above mentioned CAM 
categories include homeopathy, qigong (a practice that involves gentle physical movements 
combined with deep breathing exercises), therapeutic massage, meditation, and vitamins, 
respectively.9  
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Use of CAM therapies among cancer patients and survivors ranges from 7-64%.10 The 
variable rates of CAM use are attributed to a lack of a standard definition of CAM and the in 
differences in patient populations studied and survey methodology. While it is uncertain what the 
true measure of prevalence of CAM is in the cancer patient population, it has been documented 
that anywhere between 40% to greater than 60% of cancer patients fail to inform their physicians 
of their use of CAM.11,12 Non-disclosure of CAM use is particularly dangerous because of 
potential for some therapies to decrease medication efficiency and increase toxicity.13 
Additionally, many CAM therapies have not been thoroughly researched so it is unknown how 
these therapies may interact with conventional treatments or the patients themselves.  
To help cancer patients and survivors communicate their use of CAM to their providers, 
OCCAM developed a patient education workbook entitled, Talking about Complementary and 
Alternative Medicine with Health Care Providers: A Workbook and Tips. This workbook was 
designed after careful review of the literature, existing sources of qualitative data, and several 
cancer advocacy groups’ websites. Comprised of different adaptations of health diaries, 
OCCAM’s workbook encourages patients and survivors to track the different CAM therapies 
they use for symptom management. Documenting use and motivations of CAM, enables cancer 
patients and survivors to be participatory members in their healthcare, and provides them with 
the necessary skills to engage in conversations about CAM with their provider(s).  
This thesis covers the development of the workbook designed for the Office of Cancer 
Complementary and Alternative Medicine during the course of the author’s participation of the 
Health Communications Internship Program. The thesis outlines the conceptualization, 
development, and implementation of the workbook. Chapter Two discusses the prevalence of 
complementary and alternative medicine (CAM) use among cancer patients and survivors, the 
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motivations for CAM use, and the barriers and facilitators affecting patient-provider 
communication about CAM. Chapter Two also outlines how the qualitative data reviewed and 
use of the Health Informational National Trends Survey (HINTS) database contributed to the 
development of the workbook. Chapter Three describes the methods used during the course of 
the formative research process and pretesting phases. Chapter Four discusses the accessibility 
and presentation of CAM information by various national cancer advocacy groups. This chapter 
also describes the two rounds of pretesting that were conducted with cancer survivors, advocates, 
caregivers, and healthcare professionals and discusses the implementation of the workbook. 
Chapter Five analyzes how this workbook enhances patient-provider communication and the 
public health significance of such a communication campaign. Chapter Six provides a thesis 
summary and describes the strengths as well as the limitations of Talking about Complementary 
and Alternative Medicine with Health Care Providers: A Workbook and Tips. This chapter also 
offers recommendations for educational campaigns targeted at healthcare providers to increase 
awareness and knowledge about CAM.  
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2.0  BACKGROUND 
In 1990, the first national survey of alternative medicine use in the U.S. was conducted. Using a 
random-digit-dial (RDD) telephone survey of non-institutionalized U.S. adults, Eisenberg et al.14 
demonstrated 33.8% of adults used CAM. In 1997, Eisenberg et al.15 repeated the RDD 
telephone survey to once again measure the prevalence of CAM among U.S. adults. Between 
1990 and 1997, the prevalence rate of CAM use increased from 33.8% to 42.1%.15 This seven 
year time period also saw marked changes in the estimated total number of visits to CAM 
practitioners with 427 million office visits in 1990 and 629 million office visits in 1997.15 
Furthermore, the total number of visits to CAM practitioners in 1997 surpassed the total number 
of office visits to primary care physicians (386 million).15 Coupled with increased visits to CAM 
practitioners in 1997, the out-of-pocket expenditures for CAM therapies also increased between 
1990 and 1997, from approximately $14.6 billion to $21.2 billion, although Eisenberg et al.15 
argue that the true out-of-pocket costs for 1997 were more likely between $27.0-$34.0 billion 
dollars.  
 Beginning in 2002, the National Health Interview Survey (NHIS), a representative 
random household survey of non-institutionalized U.S. adults was used to calculate the 
prevalence of CAM.  The 2002 survey estimated the rate of CAM use among U.S. adults to be 
62% when the definition of CAM included prayer; if prayer was excluded the rate was 36%.16  In 
the analysis of CAM trends, this was the first instance in which the operationalization of the 
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CAM definition greatly affected the resulting statistics. The 2007 NHIS is the last available 
recorded national prevalence data for CAM use. Results from this survey, which did not include 
prayer for health in the definition of CAM, estimated approximately 38% of U.S. adults had used 
CAM in the previous 12 months.17 The 2007 NHIS also revealed that the out-of-pocket 
expenditures for CAM practitioners, products, classes, and materials increased to $33.9 billion 
dollars, which accounted for 1.5% of the total U.S. healthcare expenditures and 11.2% of the 
total out-of-pocket expenditures.18  Using the Medical Expenditure Panel Survey to determine the 
annual expenditures on the most common CAM therapies of credentialed providers, chiropractic 
care, acupuncture, and massage therapy, Davis et al. estimated U.S. adults spent $9 billion 
dollars each year on visits to CAM practitioners for treatment of chronic conditions.19  
The motivations for CAM use remained unchanged from 1990 through 2007. Adults 
tended to gravitate to CAM therapies to alleviate a host of chronic ailments, which included back 
pain, neck pain, arthritis, anxiety, head and chest colds, depression, and headaches.15,16 The 1997 
survey revealed women, those between the ages of 35-49, and individuals with higher education 
and higher incomes, and individuals with chronic health conditions were more likely to use 
CAM therapies.15 A 2010 survey conducted by the American Association for Retired Persons 
(AARP) and the National Center for Complementary and Alternative Medicine (NCCAM) 
observed CAM use to be highest among adults age 50-59.20 This study revealed that CAM use 
was also high for adults 30-39 (39.6%), 40-49 (40.1%), and 60-69 (41.0%).20 Among older 
adults surveyed by AARP and NCCAM, the motivations for CAM use, to alleviate pain, promote 
wellness, and treat health conditions, remained the same as previously reported, as did the use 
patterns, with more women than men and those with higher education utilizing CAM.20 
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Although the motivations for CAM use remained relatively unchanged between 1997 and 
2007, interest shifted among the different CAM modalities through this 10-year period. In 1997, 
use of herbal medicine, massage, megavitamins, self-help groups, folk remedies, energy healing, 
and homeopathy were popular among CAM users.15 However, from 2002 to 2007, interest in 
mind-body and manipulative and body-based therapies increased, with adults utilizing 
acupuncture, deep breathing exercises, massage therapy, meditation, naturopathy and yoga more 
frequently than in the past.17 By 2007, the most commonly used CAM therapies were 
nonvitamin, nonmineral natural products, such as gingko biloba, garlic and herbal remedies, deep 
breathing exercises, meditation, chiropractic or osteopathic manipulation, massage, and yoga.17 
National trends from 1990 through 2007 demonstrated an increased interest in 
complementary and alternative medicine, coupled with large out-of-pocket expenditures in 
efforts to promote wellness and relieve pain. Some of the reasons for increased public interest in 
CAM included the creation of a marketplace for CAM products and practitioners,21 the easing of 
labeling regulations on dietary supplements,21 the dissemination of CAM information through 
mass media and the Internet,16,21 the desire of patients to be actively involved with medical 
decision making,16 and dissatisfaction with conventional medicine.16 While CAM interest 
remained high among the public between 1990 and 2007, the disclosure of CAM use to 
healthcare practitioners was low. From 1990-1997, less than 40% of adults who utilized CAM 
disclosed that use to their healthcare providers.15 The 2010 survey conducted by AARP and 
NCCAM also demonstrated that the disclosure rates remained relatively unchanged from 2007, 




2.1 COMPLEMENTARY AND ALTERNATIVE MEDICINE USE IN CANCER 
Analysis of the 2002 and 2007 NHIS revealed that individuals with chronic diseases, such as 
cancer, were more likely to use CAM than the general population.16,17 In a cross sectional 
analysis of the 2002 NHIS data, Saydah et al.22 found adults diagnosed with cancer were 55% 
more likely to report ever using CAM when compared to adults without chronic diseases, and 
43% of adults with cancer reported having used CAM in the past 12 months. The authors 
suggested that CAM use may be more prevalent among individuals with chronic diseases due to 
the self-care management a chronic disease diagnosis requires.22 Mao et al.23 conducted a 
separate cross-sectional analysis of the 2002 NHIS data and found a cancer diagnosis was 
associated with an 11% greater use of CAM when compared to the general population. 
Comparisons among individuals diagnosed with cancer and individuals with other symptomatic 
chronic diseases, however, did not reveal differences in the patterns of use of CAM, but cancer 
patients were more likely to use prayer for health.23 An RDD survey of Californians with cancer 
also observed that individuals diagnosed with cancer were more likely to use CAM therapies 
than were those without cancer.24 
 Among the cancer population, utilization of CAM is quite varied, with different 
prevalence rates observed for patients in active treatment, i.e. chemotherapy and radiation, versus 
survivors. The prevalence rates for CAM use among cancer patients range from 10% to greater 
than 60%.25 In a systematic review conducted in 1998 of CAM use among cancer patients, Ernst 
et al.10 observed the average prevalence rate among studies included in the review to be 
approximately 31.4%. In a recent systematic review and meta-analysis, Horneber et al.26 found 
the current combined prevalence of CAM use by cancer patients, across all studies included in 
the review, was 40%. Among the countries included in the review, Australia, Canada, all 
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European countries, Israel, Turkey, New Zealand and the United States, the United States was 
the highest consumer of CAM.26 A secondary analysis of the 2002 NHIS estimated 39% of 
cancer survivors had used CAM at one point in their lives.27 In their analysis of the 2007 NHIS 
data, Mao et al.28 reported 66.5% of cancer survivors indicated they had ever used CAM and 
43.4% of survivors had used CAM within the past year. The variability and inconsistency of 
these prevalence rates is due to a lack of use of a uniform definition of CAM. Without a 
standardized way of describing CAM, it is hard to establish a true measure of the prevalence of 
CAM use among cancer patients. 
2.1.1 Patient Motivations for CAM Use 
While the prevalence rates for CAM use among cancer patients vary, the predictors of CAM use 
for cancer patients and survivors are similar to those of the general population. These include 
female gender, higher education, higher socioeconomic status, younger age, Caucasian27 and a 
holistic, philosophical orientation toward health.21,29 Cancer patients and survivors often turn to 
complementary and alternative medicine for alleviation of undertreated or undiagnosed 
symptoms at the tumor site, which may include insomnia, fatigue, depressed mood, and anxiety, 
recurring pain or treatment-related pain, neuropathy, and ongoing psychological distress.8,28,29 
For example, 60-90% of cancer in active treatment report cancer-related fatigue and 30-50% 
report insomnia, while 33% of survivors develop cancer-related pain even after curative 
treatment:8 all of these symptoms threaten the quality of the patients’ and survivors’ lives. 
CAM is often utilized to aid in the management of side effects, as it is often viewed as a 
less toxic approach to symptom management than conventional treatments, like the 
administration of chemotherapy or palliative medications.11,21,28,30-32 Many cancer patients 
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believe CAM therapies will help boost their immune system11,21,28,30,33 and may prevent 
secondary or recurring cancers.30,33 Patients also utilize CAM therapies because they provide 
hope11,21,34 and enhance one’s quality of life and well-being.11,21,28,30,31,33,34 Numerous studies cite 
one of the primary reasons for CAM use among cancer patients and survivors is to regain a sense 
of control.11,12,21,28,31,33-36 Patients may also seek CAM therapies due to dissatisfaction with their 
physicians21,23 or a failure of conventional therapies to meet their unique needs.12,21 In a 
telephone survey of women under age 50 with stage I to IIIA breast tumors, undergoing their 
first round of chemotherapy, patients who were dissatisfied with the decision making process at 
the beginning of chemotherapy and dissatisfied with their providers four months after beginning 
treatment were more likely to use complementary therapies.37 
2.1.2 Barriers and Facilitators to CAM Discussions 
A desire to regain a sense of control11,12,21,28,31,33-36 and to participate in treatment decisions36 
often leads cancer patients to begin to use CAM therapies. Cancer patients and survivors use a 
wide variety of CAM therapies, many of which are self-selected, rather than provider-directed 
and as a result are often not disclosed to healthcare providers. Richardson et al.11 found while 
68.7% of the cancer patients surveyed (n=435) at a comprehensive cancer center identified using 
at least one type of CAM therapy, nearly 60.6% did not disclose their CAM use to their 
providers. Yates et al.12 observed similar disclosure rates among newly diagnosed cancer patients 
receiving chemotherapy or radiation who used CAM, as 43% reported not disclosing their CAM 
use to either their oncologist or primary care physician. A recent cross-sectional survey of 
radiology patients (n=305) at an urban academic center revealed 43.6% of patients used CAM 
therapies yet only 12.1% disclosed their use of CAM to their radiation oncologist.38 This study 
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found only 21.6% of patients discussed their CAM use with at least one type of physician.38 
Analysis of the 2002 NHIS survey revealed 27.6% of cancer patients reported talking to their 
physician about CAM use.22 Among cancer survivors surveyed in the 2007 NHIS survey, 22.7% 
informed their providers of their use of CAM, while only 14.6% informed their providers of their 
herb use.28 While herb supplementation is considered a part of CAM, this is an important finding 
because it highlights the discrepancy between use of dietary supplementation and disclosure 
patterns of supplement use to healthcare providers. 
One of the primary reasons why patients are often hesitant to discuss their use of CAM 
with their providers is that they are concerned their physician will react negatively.12,31,33,35,39 
Patients are also fearful their physicians may dismiss their questions,31,33 or show a lack of 
interest in discussing CAM.12,30,35,37 Others may not disclose their use of CAM because of a 
physician’s emphasis on scientific evidence to support treatment decisions.35,39 Assumptions 
about a physician’s knowledge may also influence disclosure of CAM use, including a patient’s 
belief that his physician may have limited knowledge on the topic12,30,35 or that CAM is not 
within the physician’s scope of practice.31 Patient beliefs surrounding CAM use may also govern 
disclosure patterns. Patients may view CAM therapies as natural and safe alternatives to 
conventional medicine that do not require physician input.21,31 Lastly, patients may not inform 
their physicians of their CAM use because they did not perceive the therapy they were using as 
CAM,12 they thought it was irrelevant to the biomedical treatment course,12,21  or they simply 
were not asked by physicians about CAM use.12,31 
Equally responsible for the lack of communication about CAM are healthcare providers, 
particularly physicians. Physicians may be particularly hesitant to engage in conversations about 
CAM if they perceive they have a lack of knowledge about the topic.21,31,40 Many physicians lack 
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training in CAM31,41 and display skepticism toward CAM11,31,39,41 due to the lack of credible and 
authoritative evidence on the subject.21,31,39,40 These negative attitudes towards CAM may be the 
result of a desire to not appear uninformed.21,40 Physicians may be apprehensive about engaging 
in a potentially time-consuming conversation, in an already limited interaction.11,41 
Hann et al.42 found only 21% of oncologists surveyed initiated conversations about CAM 
with their patients, despite the fact that 48% of oncologists believed CAM conversations would 
enhance doctor-patient communications. In a cross-sectional study of physician and patient 
perceptions about CAM at M.D. Anderson Cancer Center, 80% of physicians believed non-
disclosure was due to patient fears of being discouraged or disapproved of by physicians, while 
50% of patients attributed nondisclosure of CAM to an uncertainty about the benefits and 
physicians never asking about CAM use.41 In this study, 91.7% of physician-patient CAM 
discussions were sometimes or often/very often initiated by the patients.41 Analysis of 
audiotaped consultations of Australian and New Zealand oncologists with 102 early stage breast 
cancer patients revealed 73% of CAM conversations were initiated by patients.43 In a similar 
study of 314 transcribed conversations between Australian oncologists and their patients, 66% of 
complementary therapy discussions were initiated by patients.44 
Regardless of who initiates the conversation, CAM conversations are an important 
component in oncology care as many cancer patients have been shown to utilize CAM therapies 
as part of their treatment strategies.10,25-28 To enhance the model of patient-centered care, which 
recognizes the patients as engaged members in their care, physicians need to strive to understand 
the motivations for CAM use.35Addressing a patient’s reasons for CAM use helps to identify that 
patient’s values, explanatory models, lifestyle, health beliefs, and goals for care, and may address 
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unmet needs in conventional treatment.12,21,28 Frenkel et al.35describe the merits of learning a 
patient’s belief system, arguing physicians need to: 
identify patient’s beliefs, fears, hopes, and expectations; learn what conventional 
therapies have been tried, have failed, or have been rejected because of safety, quality of 
life, cost, or other issues; make sure the patient understands prognostic factors associated 
with the stage of the disease and also understands the potential benefits of conventional 
therapy as well as its potential harm; acknowledge the patient’s spiritual and religious 
values and beliefs, including views about the end of life and seek to understand how these 
impact health care choices; discover what levels of support the patient relies on from 
family, community, faith community and friends (p290). 
 
With a plethora of information available on the Internet, in books, and in journal articles, 
informed cancer patients are bound to have questions regarding CAM’s safety, efficacy, and 
potential for interactions with conventional therapies.21 When approached with CAM questions 
physicians need to react to CAM interests in a “way that makes their patients feel comfortable 
and safe to at least disclose what CAM they are using and for what purpose.”(p367)33 
Additionally, physicians have both a legal and ethical responsibility to respect a patient’s 
autonomy and to discuss CAM.31,41 There may be instances where physicians need to exert their 
paternalism45 to dissuade patients from using therapies that have proven to be harmful, 
expensive, useless, and ineffective.35  
The first step in developing strong patient-provider relationships is to establish open, clear 
lines of communication. Establishing lines of clear communication can lead to increased patient 
satisfaction, increased medical decision making, increased quality of life, and improved health 
outcomes,21,30,35 while poor communication may result in a loss of self-efficacy and patient 
autonomy.35 Tasaki et al.39 warn physicians who disagree with patients’ use of CAM need to 
respectfully disagree with their patients’ decisions, so as not to threaten communication about 
CAM use. Keeping communication channels open between patients and providers fosters a 
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trusting and supportive relationship, in which shared decision-making can occur.30,31,35 Shared 
decision-making recognizes patients as a participatory members in their care and serves to 
empower them by providing the knowledge necessary to make good decisions about their care.35  
There are several ways physicians can create a patient-friendly atmosphere for CAM 
discussions.  The simplest strategy is to ask patients about their CAM use as part of the routine 
medical history or at important points in the illness trajectory, rather than waiting for patients to 
disclose this information.21,46 By initiating the conversation about CAM, physicians demonstrate 
they are open and receptive to talking about the subject. Another strategy is to develop effective, 
non-judgmental communication skills.30,35 Several additional evidence-based guidelines for 
patient-provider CAM discussions emerged in a systematic review conducted by Schofield et 
al.46 Among the listed guidelines were respecting cultural and linguistic diversity and actively 
listening to patients’ concerns, including their emotional state and use of CAM.46 Lastly, even if 
physicians do not subscribe to CAM use, they should be prepared to have informed, balanced 
conversations about the available evidence, including the risks and benefits with their 
patients.30,35,46    Physicians should also be prepared to conduct regular follow-ups to monitor for 
adverse reactions and therapy effectiveness.30,46  
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2.2 REVIEW OF EXISTING DATA  
2.2.1 Information Seeking Behaviors of Cancer Patients  
The HINTS database is an NCI database of biennial cross sectional surveys that monitor health 
communication trends and use patterns among adults 18 years or older. First administered in 
2002, HINTS surveys seek to determine population-level estimates of health information-seeking 
behaviors, associated with cancer communication, patient-provider communication, Internet use, 
and nutrition and physical activity. Currently there are only three datasets available on 
information-seeking behaviors, the 2003, 2005, and 2007 datasets, so whenever possible the 
2007 dataset was utilized for analysis. The HINTS database is comprised of individual survey 
questions and their responses related to cancer diagnosis and acquisition of cancer information as 
well as summary factsheets called HINTS Briefs. HINTS Briefs 10 and 16 were reviewed to 
understand the information-seeking behaviors and the communication medium preferences of 
cancer patients and survivors.  
HINTS Brief 16: Trends in Cancer Information Seeking and several HINTS survey 
questions were reviewed to learn about the different sources cancer patients use when looking for 
cancer information. Data collected in 2008 revealed nearly 40% of the American public has 
searched for cancer information, with 55.3% of the population seeking information via Internet 
searches, while only 24.9% sought cancer information from healthcare providers.47 Another 
HINTS question revealed similar trends with 61% of people reporting use of the Internet in their 
most recent attempts to learn about health topics, while only 13.9% of respondents sought their 
healthcare providers for health information.48 In 2003, the most visited sites and search engines 
for health information were Google, Mayo Clinic, MSN, WebMD and Yahoo.com.48 Despite the 
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high prevalence and easy access of Internet searches, only 18.9% of the 2007 HINTS survey 
respondents placed trust in the information found through Internet searchers, while 68.2% of 
respondents placed a lot of trust in information obtained from healthcare providers. Hesse et al.49 
hypothesized these trends correspond to the volume of data found through Internet searches, 
which often leaves patients confused and seeking the counsel of their healthcare providers to 
help decipher the information found online.  
HINTS Brief 10: Information Support for Cancer Survivors: Cancer Information Seeking 
Behaviors was also reviewed to understand the information-seeking behaviors of cancer 
survivors, since there are an estimated 12 million cancer survivors in the United States.3 National 
trends revealed 63% of cancer survivors search for cancer information, 54% of people with a 
family history of cancer search for information, and 27% of Americans with no affiliation to 
cancer diagnoses, whether personal or familiar, report searching for cancer information.50 These 
trends highlight a desire of cancer survivors to be informed about their diagnosis and treatment 
options. The 2005 HINTS survey revealed educational level was a predicator of information-
seeking behaviors, with those possessing a high school diploma or post-secondary education 
more likely to search for cancer information than those individuals without high school 
diplomas.50 Similar to the information-seeking behaviors observed among cancer patients and the 
public, survivors tend to retrieve their cancer information from Internet sources, but ultimately 
prefer to receive this information from healthcare providers.  
 However, unlike the general American public or Americans with other illnesses, during 
the first year of diagnosis, survivors were more likely to go directly to their healthcare providers 
for additional cancer information.50 From the second year through the tenth year post diagnosis, 
survivors resorted to the Internet for their cancer-specific informational needs before consulting 
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with their healthcare providers.50 In the eleventh year after diagnosis, survivors once again 
reverted to seeking information from healthcare providers first.50 The quality of the information 
available on the Internet is a primary concern among survivors, which may indicate why 
survivors turn to healthcare providers for cancer information.50  
2.2.2 Public Comment Responses from Healthcare Providers  
To determine the most salient CAM topics for cancer patients and survivors, OCCAM’s existing 
survey data was reviewed. Between April and May 2009, OCCAM conducted an online survey 
of healthcare professionals. This exploratory survey was conducted to help OCCAM better 
understand the informational needs of cancer patients with regard to CAM therapies in order to 
produce communication materials which reflected topics of interest among patients. Several 
specific groups of healthcare providers were targeted in the administration of the survey, 
including members of the Cancer Patient Education Network (CPEN), the Oncology Nursing 
Society (ONS), and the Association of Oncology Social Work (AOSW), and healthcare 
providers at NCI-designated Cancer Centers, including MD Anderson Cancer Center, Memorial 
Sloan Kettering Cancer Center, and the Dana Farber Cancer Institute. The survey was posted to 
OCCAM’s website, which allowed additional healthcare providers to respond.  
The survey included 11 questions developed to assess the informational needs of cancer 
patients with regard to CAM. The survey asked healthcare providers to consider the following 
issues (NCI Public Comment, unpublished data, 2009):  
• Please indicate which of the following organizations or type of institution you are 
affiliated with (choose all that apply):  
• Please choose the role you would primarily identify yourself with from the following: 
• Please list common issues, topics, or themes that emerge when discussing CAM with 
cancer patients. 
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• Please indicate the main reasons your patients use CAM. (For example, symptom 
management, cure, prevention of recurrence, other diseases, general health) 
• Please list the specific CAM therapies you are asked about most frequently. 
• When patients ask about specific CAM therapies, indicate what they are most interested 
in learning about those therapies (for example, safety, effectiveness, cost, and where to 
go). 
• Please comment about the most common myths or misinformation you encounter about 
CAM when talking to your patients. 
• Please describe the resources your patients use to get information about CAM. If 
possible, please list specific information such as the name of a particular organization. 
• Please comment on specific resources (for example publications, websites, databases) 
you are sharing with your patients when discussing CAM. 
• Please indicate the ways you think media stories about CAM affect cancer patients. 
• If NCI were to develop only one cancer CAM resource or service for patients, please 
describe what you think that resource should be? 
 
132 responses were obtained from healthcare providers scattered throughout the country. All 
answers were entered into NVivo software, coded independently by two members of the 
Communications and Outreach Program (COP) staff, and assessed for inter-rater reliability.  
For each issue, the top ten responses were analyzed due to their representation of the 
most common concerns and answers. Several of the themes observed in the literature were 
echoed in the responses obtained from healthcare providers. One such trend focused on the 
reasons why patients seek CAM therapies: for symptom management, to prevent recurrence, for 
general health, to reduce stress and relax, a hope for a cure, for pain management, to reduce side 
effects of conventional treatments, to augment conventional medicine, to regain control over 
their diagnosis, and to boost their immune function (NCI Public Comment, unpublished data, 
2009). Similar to the trends observed in the literature, a majority of the healthcare providers 
indicated the primary reason their patients report seeking CAM therapies is for symptom 
management (NCI Public Comment, unpublished data, 2009).  
Reasons for nondisclosure of CAM use observed in the public comment data also mirror 
those cited in the literature. Several healthcare providers noted patients’ hesitation to disclose 
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CAM use to physicians because of a fear of physician disapproval or a negative response (NCI 
Public Comment, unpublished data, 2009). When patients initiate conversations with healthcare 
providers about CAM, they are often interested in learning more about treatment efficacy, the 
cost and insurance coverage available for CAM therapies, places to seek CAM treatments, safety 
issues associated with CAM use, and how to find qualified practitioners (NCI Public Comment, 
unpublished data, 2009). The CAM therapies frequently discussed by patients include 
acupuncture, supplements and vitamins, herbs and natural supplements, massage, diet and 
nutrition, yoga, reiki (a Japanese spiritual healing practice, which involves placing ones hands 
over the patient to improve his/her life force energy), meditation, relaxation and stress 
management, and guided imagery (NCI Public Comment, unpublished data, 2009).  
Trends associated with information retrieval observed in the HINTS database47,48,50 were 
identified in the public comment data. Healthcare providers noted their patients’ primary source 
of CAM specific information was the Internet or word of mouth and the secondary source of 
information was from healthcare providers (NCI Public Comment, unpublished data, 2009). In 
addition to the websites identified from the 2003 HINTS inquiry,48 healthcare providers reported 
their patients seek cancer information from the websites of NCI-designated Cancer Centers, such 
as MD Anderson Cancer Center, the Johns Hopkins Sidney Kimmel Comprehensive Cancer 
Center, or Memorial Sloan Kettering Cancer Center, in addition to NCCAM’s and NCI’s 
websites (NCI Public Comment, unpublished data, 2009).  
When asked what type of resource the NCI should produce to educate patients about 
CAM, healthcare providers indicated the NCI should develop either a patient-friendly website or 
a printed resource (NCI Public Comment, unpublished data, 2009). This resource should provide 
patients with information on a variety of topics including specific CAM modalities, how to find 
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credentialed practitioners, and use of CAM for side effects (NCI Public Comment, unpublished 
data, 2009). One healthcare provider described the need for better patient education when it 
comes to CAM therapies, stating (NCI Public Comment, unpublished data, 2009):  
patients would like to be a part of the decision making in their care and as much as 
possible choose their treatment. Adding complementary therapies allows patients to get 
the most out of treatments for the best possible results. Many patients are not aware of the 
potential for interactions among therapies especially dietary supplements and 
chemotherapy and therefore need the best possible education. 
 
A primary limitation of this data was that it excluded patients from the survey, using healthcare 
providers as proxy responders to identify patient preferences. 
2.2.3 Patient Focus Group Transcripts  
Focus group transcripts were also reviewed to determine what topics were important to patients 
with regard to CAM use. The responses obtained in the focus groups helped to shape Thinking 
About Complementary and Alternative Medicine: A Guide for People With Cancer,51 a previous 
patient education resource about CAM produced by the Office of Cancer Complementary and 
Alternative Medicine, Office of Communications, Office of Education and Special Initiatives, 
and the National Center for Complementary and Alternative Medicine. In 2002, six, 90-minute 
focus groups were conducted with 52 cancer patients and their caregivers. The objectives of the 
focus group were to (NCI and NCCAM, unpublished data, 2003):  
• Better understand the circumstances in which cancer patients and caregivers seek out 
CAM information, including why, how, where, and when to seek it; 
• Assess what types of CAM information patients seek and how they evaluate that 
information, including questions they want answered and how they consider the source, 
criteria of evidence, legitimacy, and tone; 
• Examine patients’ challenges in finding and concerns about using CAM information and 
therapies; and 
• Determine promising format and delivery options for new and existing CAM materials, 
including but not limited to print, Internet and CD/ROM. 
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An additional six telephone interviews were conducted with patients who had chosen alternative 
therapies over conventional therapies as a treatment strategy.  
Several of the themes identified in the healthcare provider survey emerged in the focus 
group transcripts, including motivations and disclosure patterns associated with CAM use. 
Among the participants of the focus group, use of CAM varied throughout the course of 
diagnosis, with some individuals integrating CAM at the beginning of diagnosis and others 
waiting until later in the treatment course to first use CAM (NCI and NCCAM, unpublished data, 
2003). Regardless of when CAM was used, it was often associated with poor prognosis and 
quality of life and unsuccessful administration of conventional therapies (NCI and NCCAM, 
unpublished data, 2003). Of the patients who reported having used CAM therapies, many of their 
motivations were identical to those observed by the healthcare providers. Patients sought CAM 
to improve their prognosis, increase their immune system support, improve their quality of life, 
and lessen side effects. The primary sources for CAM information also reflected the trends 
observed from the healthcare provider survey and HINTS database; patients often obtained their 
information on CAM topics from the Internet but preferred to receive this information from their 
providers.  
Patients and caregivers reported a variety of responses from their physicians regarding 
CAM use. Some patients described having supportive conversations with their physicians about 
CAM, with some physicians even recommending massage, chiropractic, and acupuncture for 
symptom relief (NCI and NCCAM, unpublished data, 2003). Other patients noted negative, 
hostile, or disrespectful responses from their physicians, which threatened or dissolved their 
patient-physician relationships (NCI and NCCAM, unpublished data, 2003).  
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In addition to asking about patterns of use, sources of CAM information, and interactions 
with providers about CAM use, several questions were asked about what type of information 
patients would want in an education resource. One of the primary items patients wanted was an 
overview of CAM, the types of therapies it included, information on how to find CAM 
practitioners, and a list of helpful resources to learn new information about CAM (NCI and 
NCCAM, unpublished data, 2003). Of the potential ways to receive CAM information, 
participants stated the ideal way would be in the form of a brochure or booklet from their 
healthcare provider (NCI and NCCAM, unpublished data, 2003). 
Despite a seven-year gap between the administration of the focus group and the request 
for public comment data from healthcare providers, the trends associated with cancer patient use 
of CAM remained the same as those reported by healthcare providers. The motivations for CAM 
use in cancer patients were to improve prognosis, quality of life, and control over cancer.  The 
trends related to the preferred sources of information were also congruent with those found in the 
HINTS database47,48,50 and public comment responses (NCI Public Comment, unpublished data, 
2009). These three sets of data revealed that the primary source of CAM information is the 
Internet, although the preferred source of acquiring health information is from healthcare 
providers.   
2.2.4 Patient Education Symposium Transcripts  
Transcripts from the 2010 International Congress on Complementary Medicine Research 
(ICCMR) symposium, “What are Best Practices in Developing Cancer CAM Patient Education 
Materials,” were reviewed to provide insight to develop CAM patient education resources. This 
symposium featured health communication experts from three NCI-designated Cancer Centers, 
 23 
MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, and the Dana Farber 
Cancer Institute, “to identify the best practices on developing cancer patient education materials 
on the topic of complementary and alternative medicine (CAM)”(p1).52 One of the speakers 
emphasized a key element to always keep in mind when developing patient education resources 
is that patient education resources should be empowering (National Capitol Captioning, 
unpublished data, 2010). The other two participants expounded on this point, stating that any 
initiative undertaken should always strive to present the health information in ways that are easy 
to understand and encourage the readers to take action (National Capitol Captioning, 
unpublished data, 2010). Furthermore, they argued, if possible, health communication specialists 
should always try to keep communication campaigns simple by reducing the number of topics 
presented in each campaign (National Capitol Captioning, unpublished data, 2010).  Additional 
factors to consider are the overall purpose of the communication campaign, the size of the 
intended audience, and accessibility of new information (National Capitol Captioning, 
unpublished data, 2010). The panelists also discussed the importance of speaking with clinical 
staff about topics of interest as well as searching the literature to identify trends (National 
Capitol Captioning, unpublished data, 2010).  
Other topics discussed during the symposium revolved around the issue of health literacy. 
To increase the reach of communication initiatives, the panelists suggested communication 
materials should be written at a 6th to 8th grade reading level, should not include a lot of 
acronyms, and should try to reduce medical jargon whenever possible (National Capitol 
Captioning, unpublished data, 2010). Other ways to increase health literacy include using 
pictures to convey communication messages or incorporating more white space into the design 
(National Capitol Captioning, unpublished data, 2010). Another strategy for improving health 
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literacy is to include patients and their family members or caregivers in the design processes of 
health communication materials.  
A final topic discussed during the symposium was how frequently content should be 
updated. The choice of communication medium, content, and design of campaigns usually 
dictates the frequency with which materials need to be updated, whether every year or every 
three years (National Capitol Captioning, unpublished data, 2010). For example, websites require 
more frequent updates than print material; however the content of print material needs to 
withstand the test of time between revisions (National Capitol Captioning, unpublished data, 
2010).  Several of the topics discussed during the ICCMR symposium, including the frequency 
of content updates, communication medium selection, and health literacy, helped to lay a 
foundation of communication development guidelines for the creation of OCCAM’s patient 





3.0  METHODS 
To enhance communication between patients and healthcare providers OCCAM developed a 
patient education workbook to track use of complementary and alternative medicine, both during 
and after cancer care. Documenting use of cancer CAM therapies strengthens the model of 
patient-centered care because it enables greater communication about potentially untreated or 
undiagnosed cancer-related symptoms and may yield information about patient preferences for a 
holistic approach to their care. Development of OCCAM’s patient education workbook was 
guided by the information collected from the review of existing sources of data.  This process 
previously discussed in Chapter Two included a review of the Health Information National 
Trends Survey (HINTS) database factsheets and OCCAM’s existing qualitative data. The 
following section of this thesis will describe how the formative research processes led to the 
development, pretesting, and implementation of the workbook. 
After reviewing OCCAM’s available qualitative data, an environmental scan of various 
cancer advocacy websites was conducted. A total of 18 websites of national cancer organizations 
and advocacy groups for several of the leading types of cancer were selected for review from a 
list of 64 cancer organizations that OCCAM had previously catalogued as having at least some 
form of CAM information. Each website was reviewed to determine what type of information 
was available about CAM therapies, in what mediums this information was presented (e.g., pdfs, 
role model stories, webinars, or videos), and accessibility of the CAM information (i.e., how 
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easy it was to find CAM information on a website). Since the author lacks an extensive CAM 
background, the environmental scan was performed from the perspective of a patient or his/her 
family member seeking information about CAM.  
During the preliminary development of OCCAM’s workbook, initial healthcare provider 
feedback was obtained from members of the American Society for Clinical Oncologists.  
Additional feedback was obtained via email outreach from members of NCI’s Office of 
Communications and Education (OCE). 
To test the functionality and usability of the workbook, OCCAM conducted two rounds 
of pretesting. During the first round of pretesting, OCCAM utilized Open Call Testing to collect 
feedback.  Open Call Testing is a form of usability testing or pretesting sponsored by the NCI 
and conducted through the Office of Market Research and Evaluation (OMRE) to test 
communication materials. Offered bimonthly, usability testing combines two-to-four 
communication projects, including brochures, workbooks, websites, videos, and pamphlets into 
one aggregate project (User Center Designs, Inc., unpublished data, 2012). During usability 
testing, project designers, web portal managers, and content managers are provided an 
opportunity to collect qualitative data on their work from members of the general public. 
Additional feedback strategies employed during the first round of pretesting included an 
interview with a Medical Oncology Clinical Fellow and two in-services with members of the 
nursing staff of 3 SE South Hematology/Oncology Day Hospital at the NIH’s Clinical Center. 
Email outreach was also conducted with members of the NIH’s Clinical Center Department of 
Social Work.  
The second round of pretesting was comprised entirely of email outreach. The Office of 
Advocacy Relations’ (OAR) Consumer Advocates in Research and Related Activities (CARRA) 
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program was utilized to acquire contact information for cancer advocates, including survivors, 
caregivers, and advocates, willing to review OCCAM’s workbook. Healthcare provider contact 
information was obtained internally from OCCAM’s Director, Dr. Jeffrey D. White and 
OCCAM’s Case Review and Intramural Science Program Director, Dr. Farah Zia.  
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4.0  RESULTS  
This section describes how the information obtained from the literature review, existing data 
review and environmental scan were synthesized to develop Talking about Complementary and 
Alternative Medicine with Health Care Providers: A Workbook and Tips. Also detailed in this 
section are the results of the two rounds of pretesting, including the revisions that were made 
after each subsequent round of testing. Finally, a description of each of the workbook pages and 
the rationale for the creation of the overall work are provided.  
4.1 FORMATIVE RESEARCH RESULTS  
4.1.1 Environment Scan of Cancer Advocacy Websites  
Of the 18 cancer organizations in the sample, several national organizations including the 
American Cancer Society (ACS), the Leukemia and Lymphoma Society (LLS), the Livestrong 
Foundation (Livestrong), and Susan G. Komen for the Cure (Komen) were reviewed for their 
CAM content. Additional specific cancer site advocacy groups’ websites were also reviewed 
including BreastCancer.org, Breast Cancer Action, the Colon Cancer Alliance, the Hirshberg 
Foundation for Pancreatic Cancer, the Lung Cancer Alliance, the National Brain Tumor Society, 
the National Ovarian Cancer Coalition, the Prostate Cancer Foundation, and ProstateNet.org. 
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Other advocacy groups included in the scan included the Alliance of State Pain Initiatives, the 
Cancer Journey.org, Patient Advocates for the Advanced Cancer Treatment, Patients Against 
Lymphoma, and the Wings Cancer Foundation. The websites for each of advocacy organizations 
reviewed are listed in Appendix A. 
Comparisons of the national organizations revealed drastic differences in the volume of 
CAM information available and ease of information retrieval: the ACS, Komen, and LLS 
websites were much easier to navigate than Livestrong. On the Livestrong website, there was no 
discernible CAM section, and CAM information was embedded within the body of the text and 
usually at the bottom of the webpage. For example, on Livestrong’s Neuropathy page, examples 
of complementary therapies, which might alleviate some of the symptoms associated with 
neuropathy, are presented as a list of therapies, with no description. Additionally, utilizing the 
search field for “complementary and alternative medicine” yielded no search results. Therefore it 
was determined the Livestrong Foundation’s website was not a good resource for extensive 
CAM information.   
In contrast with the Livestrong Foundation’s website, the Susan G. Komen for the Cure 
(Komen) website was an example of an outstanding resource for CAM information. Not only 
was all of the CAM information located on a central webpage, but it was also presented in a 
highly organized way. Anyone seeking CAM information could search for specific topics of 
interest either by the therapy name or class of therapy. For example, information about 
acupuncture is found within the master list of CAM therapies, and listed under the Manipulative 
and Body-Based Practices.  
When a CAM topic is selected from the list of 75 available topics, an entire webpage 
opens that provides a brief background, a list of synonyms for the therapy, and an explanation as 
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to why the therapy is or is not beneficial. In addition, the scientific evidence indicating the safety 
and efficacy of a therapy is described for a variety of symptoms and diseases and given a ranking 
of “A” to “F.” A letter grade of “A” represents strong scientific evidence for the application of 
use. For example, use of acupuncture to treat chronic pain receives an “A”, while omega-3 
supplementation for diabetes receives a “D,” which indicates there is a lack of sufficient 
scientific evidence to support its use. The CancerJourney.org also provides similar rankings of 
therapies in terms of their effectiveness for anxiety, fatigue, depression, and nausea and 
vomiting, but labels the effectiveness for each therapy most helpful, likely to be helpful, and not 
enough evidence. 
Besides offering comprehensive information on various CAM therapies, the Komen 
website provides information on common topics associated with CAM use, such as safety and 
efficacy, locating CAM practitioners, finding CAM clinical trials, and questions to ask your 
providers. A strength of this website is that it provides CAM information in a variety of 
communication mediums, which include html webpage text, PDFs, videos, podcasts, and 
interviews with survivors, and booklets, such as Feel Better During Breast Cancer Treatment: 
Learn How Integrative and Complementary Therapies Can Help.  
Other breast cancer advocacy sites, such as Breast Cancer Action and BreastCancer.org 
were also reviewed. Breast Cancer Action is a grassroots education and advocacy organization 
located in San Francisco and does not contain readily available CAM information on its site. 
Discussions of CAM are focused in Breast Cancer Action newsletters only. Unlike Breast Cancer 
Action, BreastCancer.org contains a wealth of CAM information. Some of the resources 
available on this site include strategies for talking to your doctor about CAM, tips regarding 
safety and effectiveness, and sheets summarizing a variety of CAM therapies. Each summary 
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sheet provides an overview of the therapy, expectations for use, practitioner certification 
requirements, current scientific evidence, and possible complications. These descriptive sheets 
are available for acupuncture, aromatherapy, chiropractic therapy, guided imagery, hypnosis, 
journaling, massage, meditation, music therapy, progressive muscle relaxation, reiki, tai chi, and 
yoga. This site also features quotes from women who have used CAM and found the integration 
of these therapies helpful as well as comments from healthcare providers citing the validity of 
including CAM in treatment regimens.  
Similar to Komen’s and BreastCancer.org’s websites, the American Cancer Society’s 
(ACS) website contains a myriad of CAM information. The information available is much more 
extensive than that on Komen’s, but that is to be expected as the American Cancer Society is the 
largest non-profit volunteer health organization in the United States. For example, there are over 
300 CAM modalities fact sheets available for review. Each fact sheet provides the user with an 
overview of the therapy, a history of the use of the therapy, how it is intended to be used, 
scientific evidence surrounding the therapy, any complications which may arise as a result of 
using the therapy, and additional resources for more information. Additional information on the 
CAM portal of the ACS’s website includes an overview of CAM, explanations about dietary 
supplement safety, and explanations of five different classes of CAM therapies, mind, body and 
spirit, manual healing and physical touch, herbs, vitamins, and minerals, diet and nutrition, and 
pharmacological and biological treatments. ACS employs many of the same communication 
mediums as Komen to disseminate CAM information including pdfs, videos, booklets, survivor 
interviews, and podcasts. In addition, the American Cancer Society has published a book53, The 
American Cancer Society Complete Guide to Complementary and Alternative Cancer Therapies, 
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2nd Edition, to help cancer patients, caregivers, and the public understand the field of CAM as 
well as therapies classified as CAM. 
 Most of the websites reviewed were not as thorough as the American Cancer Society in 
terms of available CAM information and accessibility of this information. In fact, most of the 
websites featured a brief, basic discussion of CAM. A majority of the information about CAM 
on these sites is often embedded within website sections dedicated to symptom management and 
treatment options or located in larger discussions of quality of life issues. For example, the 
Leukemia and Lymphoma Society (LLS), the National Ovarian Cancer Coalition, and the 
National Brain Tumor Foundation all provide a description of CAM on their websites, but more 
thorough explanations of CAM, including an overview of CAM, its major categories, and the 
associated risks and benefits of CAM use, occur in their patient education resources. These 
publications included the LLS’s thirteen-page booklet about CAM, Integrative Medicine and 
Complementary and Alternative Therapies as Part of Blood Cancer Care, the National Ovarian 
Cancer Coalition’s patient education resource, Ovarian Cancer Quality of Life Issues, and the 
National Brain Tumor Society’s publication The Essential Guide to Brain Tumors. In contrast, 
the Prostate Cancer Foundation does not provide a direct description or overview of CAM 
therapies on its website. Instead it uses its publication, Nutrition, Exercise and Prostate Cancer, 
to discuss the role of exercise and nutrition, including the use of supplements, antioxidants, and 
phytochemicals in prostate cancer diagnoses. 
Other sites like the Colon Cancer Alliance, Hirshberg Foundation for Pancreatic Cancer, 
the Lung Cancer Alliance, and ProstateNet provide patients with rudimentary explanations of 
CAM and refer patients to outside resources such as NCCAM’s or OCCAM’s website for more 
CAM information. While sites like the Wings Foundation or the CancerJourney.org recommend 
 33 
specific types of therapies such as nutritional counseling, meditation, yoga, labyrinth walking or 
massage for pain, they do not provide overarching discussions of CAM. Still other sites such as 
Patient Advocates for the Advanced Treatment and the Alliance of State Pain Initiatives do not 
provide any CAM information, whatsoever.  
Similar to the analysis of CAM trends, classification of CAM therapies, and definitions 
applied to CAM, great variability was observed in the content, organization, accessibility, and 
presentation of CAM information in the small survey of cancer advocacy websites.  These 
inconsistencies may be due to the size and scope of the organizations and the resources each 
organization has available towards patient education and website maintenance. Organizations 
like Susan G. Komen for the Cure and the American Cancer Society should have extensive 
information and patient friendly websites, due to their size, brand recognition, advocacy efforts, 
and budgets. Other reasons for such differences between websites may include organizational 
support of CAM therapies, organizational confidence discussing CAM, and marketing of CAM, 
i.e. as separate tabs on websites or embedded within larger patient education efforts. It is no 
surprise then, that of the websites surveyed, ACS and Komen provided the best explanations of 
CAM. These sites not only thoroughly described the categories of CAM and the individual CAM 
therapies, by providing explanations on the safety, effectiveness, and rationale for use, but they 
were also easy to navigate.  
In addition to reviewing cancer advocacy websites, three NCI-designated Cancer 
Centers’ websites (MD Anderson Cancer Center, Memorial Sloan Kettering Cancer Center, and 
the Dana Farber Cancer Institute) were also analyzed. These three were chosen because of their 
national recognition as leading cancer centers. Similar to the presentation of CAM in the various 
advocacy groups surveyed, each cancer center’s patient education department was very different. 
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For example, the Leonard P. Zakim Center for Integrative Therapies at Dana Farber Cancer 
Center used a variety of communication modalities to discuss CAM; these included html 
webpages, PDFs, YouTube videos, and role model stories describing patient’s experiences using 
CAM therapies. This website also details the available therapies Dana Farber Cancer Center 
offers, which include acupuncture, nutrition services, creative arts, music therapy, qigong, and 
reiki.  
Memorial Sloan Kettering Cancer Center’s website provides some information on 
treatments available at the hospital, acupuncture, exercise, and art therapy, as well as information 
on current research endeavors and active clinical trials. This site features several videos that 
explain common concerns associated with CAM use, demonstrate yoga breathing techniques, 
discuss herbal use during survivorship, and describe the role of therapeutic touch for symptom 
alleviation.  The website also includes an extensive database of evidence-based information for 
over 200 herbs about the uses, pharmacokinetics, adverse reactions, warnings, and herb-drug 
interactions. This database is available online and in mobile app format for healthcare providers 
and patients. 
Similar to Memorial Sloan Kettering and Dana Farber’s Integrative Medicine websites, 
MD Anderson Cancer Center provides a wealth of information for patients about complementary 
therapies and clinical trials. Information on the various CAM therapies is organized by the 
category of therapy, including but not limited to energy therapies, manipulative and body-based 
methods, and mind-body approaches. Thorough explanations of both the CAM category as well 
as the individual therapy are provided. This website contains an extensive list of books, websites, 
periodicals, government resources, and academic centers which feature either general or cancer-
specific CAM information along with ongoing lecture series at MD Anderson. Unlike the 
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websites of the Dana Farber Cancer Institute or Memorial Sloan Kettering Cancer Center, a 
small section of the Integrative Medicine resources are dedicated to discussing patient-provider 
conversations.  
4.1.2 Discussing CAM with Healthcare Providers 
Information about the importance of talking to healthcare providers about CAM use was present 
on all websites that provided an overview of CAM. Most of the sites reviewed featured this 
information in the form of bulleted lists of tips patients can employ to facilitate CAM 
conversations. However, the American Cancer Society and Susan G. Komen for the Cure 
developed specific patient education resources to help guide patients on how to talk to their 
providers, including sample questions to ask. Instructions to speak with one’s healthcare provider 
were usually preceded by warnings about CAM’s potential interactions with prescription 
medicines and other conventional treatments. 
NCCAM designed a communication campaign to specifically address this very issue. The 
Time to Talk campaign educates both patients and providers about the importance of talking to 
one another about CAM, regardless if the intended use of CAM is preventative or curative. Time 
to Talk provides guidelines for patients, providers, and community members to engage in 
conversations about CAM use. This campaign features strategies designed to help patients and 
providers talk about CAM use as well as explanations as to why these conversations are 
important. The campaign resources also include wallet cards for patients to document their 
medications, including vitamins, herbs, and dietary supplements; posters and brochures for 
healthcare providers to promote such conversations; and widgets, which can be placed on other 
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websites to increase awareness about NCCAM’s campaign and the need to change patient-
provider dialogues regarding CAM use.  
 
4.2 PRETESTING: ROUND ONE 
 
4.2.1 Preliminary Pretesting Efforts 
Throughout the development of the patient education workbook, OCCAM sought feedback on 
the design, functionality, and utility of its design at various draft phases. The first pretesting 
efforts were employed in June 2012 at the American Society of Clinical Oncologists’ annual 
meeting in the form of public comment requests. Under the Paperwork Reduction Act (PRA) of 
the Office of Management and Budget (OMB), there is a limit to the number of people who can 
be surveyed without requiring official clearance and approval. Established in 1995, the PRA 
seeks to monitor the processes by which information is obtained by or for the government from 
the public.54 Per the PRA,54 “information collection must be cleared by OMB if an agency 
collections information from ten or more people, regardless of whether the collection is 
mandatory, voluntary, or required to obtain or retain a benefit during the following 
circumstances:  
• When an agency obtains, causes to be obtained, solicits, or requires the disclosure 
• To an agency, third party or the public of information 




By utilizing public comments, or open-ended, unstructured questions, OMB clearance was not 
needed in order to solicit feedback from conference attendees.54 
OCCAM’s Office of Communication and Education (OCE) liaison, Shea Buckman Manley, 
facilitated collection of responses by asking attendees who visited her booth at the conference to 
respond to the following comments: 
• Please describe your experience talking with patients about their complementary and 
alternative medicine (CAM) use and beliefs (e.g. yoga, vitamins, acupuncture) and 
whether or not you believe this resource would encourage useful conversations about 
CAM in your practice. 
• Identify whether patients keeping track of their CAM use in these logs may help you 
enhance their care.  
• Identify how you or your office staff would use this resource. 
 
Four physicians, three Medical Doctors (M.D.s) and one Doctor of Osteopathic Medicine (D.O.) 
provided comments on OCCAM’s workbook. Three of the physicians noted the resource would 
be helpful and that they liked the overall design of the workbook. Two of the workbook pages 
that resonated with the physicians were the medication list and the provider list because these 
pages provide useful information for all members of the healthcare team (S.B. Manley, email 
communication, 2012). Some of the suggestions were to add a section on patient rights and 
responsibilities, include more spaces to list medications, create more space to list CAM 
therapies, and provide patients with information about CAM clinical trials (S.B. Manley, email 
communication, 2012). One physician was concerned about the potential “set-up” and unrealistic 
expectations to discuss all of the workbook topics within one clinical visit. These initial 
comments provided an early validation that there was in fact a need for a resource designed to 
improve communication between patients and providers about CAM.  
Additional preliminary feedback endeavors included review of OCCAM’s material by 
two members of OCE’s staff. Direct feedback was not provided on the utility of the materials by 
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the OCE staff; instead, suggestions were provided on how to lower the reading level of the 
document. One suggestion was to simplify the medical terminology used throughout the 
document, making such changes as switching the word “medication” to “medicine” on the 
medicine list (S.B. Manley, email communication, 2012). An additional suggestion was to 
change the text of the document from the third person to first person to better engage the reader. 
For example, the questions on Why I want to use CAM were changed from “Why are you 
interested in using complementary or integrative therapies with your cancer treatment?” to “I am 
interested in using CAM because” (S.B. Manley, email communication, 2012).  Other 
suggestions were to reduce the length of the sentences, simplify the instructions, and reduce the 
overall amount of text used in the workbook (S.B. Manley, email communication, 2012). 
4.2.2 Open Call Testing 
On July 17-18 2012, OCCAM participated in usability testing along with two other offices, the 
Office of the National Coordinator (ONC) and the Office of Biorepositories and Biospecimen 
Research (OBBR).  Prior to the pretesting sessions, several meetings were held with the OMRE, 
OCCAM, and OBBR to establish screening criteria, testing goals and objectives, and to develop 
a moderator’s guide for the pretesting session. Each Open Call Testing session is capped at nine 
people so as to not require OMB clearance.54 Due to the sample size restrictions, OMRE 
facilitated a meeting with OBBR and OCCAM to determine what types of individuals each 
project required for optimal feedback, and together the two offices established a set of 
recruitment criteria. ONC was not involved in the initial recruitment meetings due to its late 
addition to the testing schedule for the month of July. Since the patient education booklet was 
not targeted to any one particular group, OCCAM was not restrictive with the recruitment 
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criteria, but instead encouraged a variety of participants with different demographic 
characteristics. The only criterion OCCAM requested was that some of the participants had some 
familiarity with CAM therapies, so that time would not be spent explaining CAM. In order to 
assist with recruitment, OCCAM developed two CAM specific screening questions (see 
Appendix B 1.1).  
 User Centered Design, Inc., an independent firm that conducts usability testing for a 
variety of non-profit, industry, and governmental organizations, including the National Cancer 
Institute, recruited the study participants (User Center Design, Inc., unpublished data, 2012). 
Despite sampling restrictions, an even distribution among racial categories was achieved, with 
three African American participants, three Caucasian participants, and three Caucasian-
Hispanics participants (see Appendix C, Table 1). Additionally, a range ages were represented 
and both men and women were included in the usability testing sessions. The educational level 
of the participants was fairly high and consistent.  
OMRE, OCCAM, OBBR and User Centered Design, Inc. held an additional meeting to 
draft the moderator’s guide for the focus group. Each office was asked to provide its objectives 
and questions for testing (see Appendix B.1.2). OCCAM’s primary objectives for testing were to 
determine if the material, as written, was understandable; whether patients would utilize a 
workbook designed to track CAM use, if so, how and which pieces; and whether a patient 
education resource would help patients discuss complementary and alternative medicine with 
their doctor. A secondary focus of testing was to determine participant preference for images, 
color, text, and layout. The final moderator’s guide (see Appendix B.1.3) was distributed to each 
group for review prior to testing, and captured a majority of topics OCCAM was interested in 
investigating.  
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Usability testing was conducted over the course of two days. The nine testing sessions 
were recorded allowing members from OCCAM, OBBR, and ONC to observe the interactions 
between the moderator and the participant. Each testing session lasted approximately one hour, 
with 17 minutes allotted for each of the three group’s communication products (User Center Inc., 
unpublished data, 2012). Due to the limited amount of time with each participant, OCCAM 
selected three workbook pages for review, Why I want to use CAM (see, Appendix B, Figures 1 
and 2), My weekly CAM use (see, Appendix B, Figures 3 and 4), and the cover (see, Appendix B, 
Figures 5 and 6). Two versions of each tested page were developed with specific criteria to 
evaluate the design elements and utility. Another set of objectives for usability testing included 
determining participant preference for completing the workbook pages, with each participant 
offered the opportunity to fill in the requested information either on printed forms or online 
versions of each form.  
At the start of each testing session the moderator asked participants whether they were 
familiar with the term complementary and alternative medicine. If a participant was familiar with 
CAM he was asked to provide examples of specific CAM therapies that he had used. If a 
participant was not familiar with CAM, he was provided a brief definition as well as a list of 
examples of CAM therapies that included but were not limited to yoga, meditation, tai chi, 
supplements, and acupuncture, so that he would have some familiarity with CAM in order to fill 
out the information in the worksheets. Of the nine total participants, six participants were at least 
somewhat familiar with CAM. 
Next, participants were asked their preference for online versions or printed worksheets. 
A majority of participants began the testing session using online versions of each document but 
later switched to paper documents to complete the testing session. Participants were shown either 
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version A or B during their testing session and asked to provide comments on each workbook 
page, as prompted by the facilitator. Before the end of each testing session, participants were 
shown the alternate versions of each document and asked to indicate which they preferred.  
Participants were first shown was Why I want to use CAM (Appendix B, Figures 1 and 2). 
Participants were asked to provide their thoughts about the utility of this worksheet. Two of the 
participants recognized the value of documenting their questions, concerns, and CAM interests 
prior to visits with their provider(s) to engage in better health conversations. Another participant 
was concerned with the inherent assumptions underscored on Why I want to use CAM: she felt 
this document assumes the patient is “knowledgeable about CAM.” Several other participants 
echoed her concerns indicating that it would be helpful to have a list of CAM modalities 
included in the workbook for reference prior to completing Why I want to use CAM.  
Additional questions were asked about the two versions, A and B, (Appendix B, Figures 
1 and 2) with regard to image selection and text box size and placement since the content of each 
version was identical. A majority of participants preferred the linear arrangement of version A to 
that of version B.  However, many preferred the images of version B to that of version A because 
they were more discernible.  
Finally, participants were asked whether this workbook would aid discussions of CAM 
use with their providers. One participant indicated she would have found this resource helpful at 
the time of diagnosis to help facilitate discussions with her providers. Another participant 
explained she would be more likely to discuss CAM use with her oncologist than primary care 
physician because her oncologist supported trial of therapies that make her “feel good.” 
The second worksheet participants were asked to review was My weekly CAM use 
(Appendix B, Figures 3 and 4). Two versions of this document were shown to participants; 
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version A had labeled columns with rows for the days of the week, which allowed only three 
CAM therapies to be tracked per day, or version B, an unlabeled version, which allowed patients 
customize the number of CAM therapies they tracked per day. Those participants who were 
shown version B found the unlabeled version to be confusing, preferring to have both the 
gridlines and days of the week clearly delineated.  
Participants were also asked to comment on the column headings and usefulness of 
tracking conventional therapies. Most participants felt the column headings were 
straightforward; however, one participant suggested changing the last column’s heading from 
“how did it make you feel” to “notes.” She argued it is impossible to attribute “relief” to any one 
therapy when “multiple therapies” are used simultaneously. Regardless of the version reviewed, 
some participants struggled to understand what the term “conventional therapies” referred to; 
they did not understand that it was synonymous with standard treatments.  
Since the content of the two versions, A and B was identical, a majority of the questions 
about My weekly CAM use were centered on its usefulness. Several participants stated they 
would be more likely to use this document for personal use rather than for sharing the 
information with their physician. One participant suggested documenting CAM therapies and 
their effects on symptom management might be useful to obtain “insurance authorization” for 
certain CAM therapies, since tracking CAM use could demonstrate an improvement of 
symptoms through use of the particular therapy/ies. Several other participants admitted they 
would not track their CAM use in such an organized way because they were not as disciplined as 
they should be. However, most participants stated they would fill out this form if their healthcare 
provider gave it to them.  
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Two participants had concerns about tracking CAM use on a weekly basis, particularly 
when receiving cancer treatments. They stressed during the active phase of treatment, patients 
are grappling with the emotional, psychological, and physical ramifications of cancer diagnoses 
and treatments, so tracking CAM use on a weekly basis may be “too taxing” for some patients. 
Plus some patients may rely on caretakers to “keep track of medications” and act as their 
advocates because they are simply too ill.  A concern was also raised about the amount of time 
needed to feel the “effect of a treatment” and the restrictions of being able to document only 
three CAM therapies per day. One participant suggested creating a monthly tracking log instead 
of a weekly calendar to increase the breadth and scope of CAM therapies captured as well as 
their effect. 
The last workbook page that participants reviewed was the front cover. Two versions of 
the cover were produced (Appendix B, Figures 5 and 6). Version A of the cover displayed 
predominantly cool colors and darker images, with the title Talking about Complementary and 
Alternative Medicine Use with Your Doctor: A Guide for Cancer Patients, while version B had 
warmer colors, images of patient-provider interactions, and the title A workbook and tips to 
improve communication with your doctor about complementary and alternative medicine. 
Participants were asked to evaluate several aspects of the cover design, including title, use of the 
term “workbook” versus “guide,” color and image selection, and placement of the OCCAM’s 
office banner. Study participants did not reach consensus on the title or color preference with 
five of nine participants preferring the terms “workbook” and “tips” to “guide” and five of nine 
people favoring an orange banner bar to a blue bar. As for the location of the office banner bar, it 
was determined it should be a small box placed near the top of the document to inform the reader 
who produced the work, but should not detract from the workbook title. 
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As for the number and types of images, some participants felt there were too many 
images on the orange cover (Appendix B, Figure 6). Participants noted that when viewing health 
communication materials, they preferred to see healthy, smiling people because they “make 
people feel positive.” Participants also suggested the selected CAM images on the cover should 
be of therapies people would recognize. One participant associated the meditation photo featured 
on version A of the cover with “the darkness of cancer,” while the yoga image on the same cover 
was correlated with “health” and “exercising.”  
When time permitted, participants were also asked to give their opinions about My 
complete medicine list and Members of my health care team. The majority of participants felt 
both forms would be very helpful and appreciated the layout of each document that separated the 
information into various categories. Of the forms included in the workbook, participants felt My 
complete medicine list would be most helpful in communicating interests with physicians, due to 
the frequency with which patients are asked about their medication use. Participants liked the 
separate categories for prescriptions, over-the-counter (OTC), and vitamins, herbs, and dietary 
supplements because several participants did not consider supplements “as medicine.”  The 
primary complaints about My complete medicine list were the size of the cells and not being able 
to track all of their medications within the allocated spaces. Three participants also discussed 
how they would be more likely to utilize the provider contact list for personal use, but would be 
willing to show their providers, if they wished to establish coordinated care plans.  
4.2.3 NIH Clinical Center 3 South East South Oncology Nurses 
Pretesting with the healthcare providers coincided with preparations for Open Call Testing. 
Outreach efforts for the month of July 2012 were primarily concentrated with healthcare 
 45 
professionals located in the NIH’s Clinical Center. The Clinical Center is a world-renowned 
medical research hospital located at the heart of the NIH’s main campus. OCCAM’s OCE 
liaison, Shea Buckman Manley, identified a nurse manager of an oncology unit located within 
the Clinical Center, 3 SE South Hematology/Oncology Day Hospital (3 SE South), whom she 
believed would be willing to provide feedback on OCCAM’s project. This professional contact 
had previous experience collaborating with NCI offices on patient education projects.  Through 
email correspondences and an in-person meeting between the author and the nurse manager, 
strategies were developed to obtain feedback from her nursing staff. It was suggested the author 
conduct an in-service with the nursing staff of 3 SE South during one of their morning staff 
meetings. 
3 SE South Hematology/Oncology Day Hospital is comprised of 20 to 25 nurses, with a 
variety of nursing expertise in the public and government sectors. The nurses of 3 SE South 
monitor the health and safety of oncology patients who are involved in NIH clinical research 
trials and are often placed under strict protocols for medications.55 Since the clinical environment 
of 3 SE South is not reflective of public or private hospital oncology floors, the nursing staff was 
asked to evaluate OCCAM’s workbook as healthcare providers and not as federal Clinical Center 
employees, since utilization of CAM therapies by 3 SE South’s patients is often restricted due to 
clinical trial protocols.  
About one week after meeting with 3 SE South’s unit director, the author provided an in-
service presentation for eight members of the nursing staff about OCCAM’s initiative. During 
the staff meeting, the author described the purpose of the campaign, presented the two workbook 
versions, and explained the questions OCCAM wanted to have answered during the review 
process. Samples of each version of the workbook as well as feedback tracking forms were left 
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with the nursing staff for a period of two weeks. The feedback tracking forms enabled nursing 
staff to evaluate each workbook page, making any notes about specific pages while answering 
the questions regarding utility of the workbook (see Appendix B.1.5 and Figure 7). A second in-
service for approximately 10 to 12 nurses was conducted two weeks after the first presentation 
was held.  
From the two in-services conducted with staff members of 3 SE South, six feedback 
forms were completed. The nursing staff that responded to OCCAM’s inquiry had favorable 
reactions to the workbook. Most nurses believed OCCAM’s workbook was a “good resource” 
that would be “valuable/useful” for patients and caregivers as well as nurses, doctors, social 
workers, dietitians, pain/palliative care coordinators, and nutritionists. One nurse believed My 
complete medicine list, Why I want to use CAM, and Members of my healthcare team would be 
most helpful for patients. Every nurse who provided feedback indicated she thought this resource 
was helpful and would recommend the workbook patients.  
Similar to the patient population, the nurses were asked to evaluate each page of the 
workbook, paying particular attention to the two versions of the cover, Why I want to use CAM 
and My weekly CAM use (Appendix B, Figures 1-6). Since the feedback forms were left with the 
nurses to fill out at their leisure, comments were obtained for mostly every workbook page. 
However, unlike the patient population, when comments were rendered the answers provided by 
the nurses were more succinct because they were written. There were no responses regarding 
preference for version A or B’s cover design, title, or layout. The comments for Why I want to 
use CAM mirrored those of the patient population; the nurses suggested adding a list of CAM 
therapies prior to this worksheet to assist patients in filling out their motivations for CAM use. 
Similar to the participant reactions to My weekly CAM use, some nurses believed this resource 
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might be more helpful for patients, than healthcare providers, as they “test out” the effects of 
different therapies on their symptomology. Many of the nurses conceded that the information 
was still valuable and important for nurses to know as it connected “actions and results” of use of 
CAM for symptom relief.  
A primary concern with the design of the workbook was the amount of space present in 
the medication list. Several nurses stressed many cancer patients medication regimens include 
more prescription medications, in effort to manage both the cancer as well as potential 
comorbidities than OTCs or vitamins, herbs, and dietary supplements. It was advised to include 
more spaces for prescription medications and reduce the space for OTC and nutritional 
supplements. An additional expressed concern was associated with the reading level of 
OCCAM’s workbook. One nurse suggested creating simpler versions of the workbook pages 
written at a “6th grade reading level.”  
4.2.4 NIH Clinical Center Medical Oncology Branch Clinical Fellow 
On July 9, 2012, the author conducted an hour-long interview with a Medical Oncology Branch 
Clinical Fellow regarding the use and utility of OCCAM’s workbook. During the course of the 
interview, the medical oncologist was asked the same set of questions as the nursing staff 
(Appendix B.1.5) and asked to review each workbook page.  The Fellow’s overall impressions of 
the workbook, similar to the nursing staff, were positive. He felt this resource would be very 
helpful for physicians to acquire additional “information” about patients’ coping mechanisms, 
which is “generally” not disclosed, including their use of CAM. He stated he would recommend 
this resource to seasoned and novice CAM users alike as well as patients who “expressed 
interest” in incorporating CAM into their treatment regimen.  
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Of the workbook pages, the medication list received the greatest praise from the 
Oncology Fellow. He believed documentation of all medication would “stimulate dialogue” 
between patients and providers about the different types of medications used (prescription, OTC, 
and supplements), medication adherence, side effects, and potential interactions in addition to 
increasing “awareness” among physicians about the use of supplementation. The Oncology 
Fellow had a more favorable response to My weekly CAM use than the nurses, reiterating 
“documentation” of patient coping strategies outside of the clinical environment is always 
“helpful.” He appreciated the “concise and organized” format of My weekly CAM use. 
In addition to providing positive feedback on the resource, the Fellow gave a lot of 
constructive criticism during the course of the interview. He expressed concerns, similar to those 
of the nurses of 3 SE South, about the breadth and health literacy level of the workbook. To 
improve use and utility of the workbook, he advised creating a simplified version of the 
workbook so as not to “overwhelm” patients who might not be familiar with CAM and might be 
experimenting with its use for symptom alleviation or health management. He also suggested 
that OCCAM should redefine its use of standard of care, providing an anecdotal story a 
Ukrainian patient who consumed an herbal tea daily, which to him was a standard of care, but 
greatly interfered with his electrolyte balance. The last suggestion was to include more 
cautionary language within the booklet about the dangers associated with CAM use, particularly 
because of the “vulnerability of cancer patients.” Unfortunately, there are many websites and 
products that prey upon cancer patients’ desire to find additional therapies, medicines, or cures 
for their cancers by claiming that their products prevent or reduce cancer recurrence or can cure 
cancer. Extreme caution should always be utilized when purchasing supplements. The Food and 
Drug Administration (FDA) does not regulate dietary supplements in the same manner as 
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prescription drugs, requiring proven safety and effectiveness prior to marketing, but they are 
monitored for adverse effects.  
4.2.5 NIH Clinical Center Department of Social Work  
During a cancer diagnosis, there are many different types of healthcare providers with whom 
patients come in contact, including social workers. A member of the NIH’s Department of Social 
Work provided his critiques of the workbook. Similar to the other healthcare providers 
contacted, the social worker was provided an electronic copy of the workbook and asked to 
review both the document and the list of questions (Appendix B.1.5). Nearly all of the questions 
posed to the social worker were identical to those posed to the nurse and medical oncologist, 
with the exception of one question that was changed to be more reflective of the field of social 
work: Identify how and when you would use a resource such as this with your patients. Upon 
review of the workbook, the social worker believed OCCAM’s project would in fact strengthen 
communication efforts between patients and providers because this workbook facilitates 
documentation and discussion of CAM use, yielding valuable information for providers about 
patients’ “ability to cope” with their cancer diagnoses. 
4.3 CHANGES IMPLEMENTED AFTER ROUND ONE OF PRETESTING 
OCCAM’s first round of pretesting yielded a wealth of information surrounding the design, 
functionality, and utility of the workbook. As a result of the testing efforts several changes were 
made to the workbook pages. Based on the suggestion of several survivors as well as healthcare 
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providers, a list of CAM therapies was created to be included in the workbook prior to Why I 
want to use CAM. This new workbook page, Understanding cancer CAM terminology, provides 
an explanation of the different CAM descriptors, integrative medicine, complementary medicine, 
alternative medicine, complementary and alternative medicine, and also provides a list of 
commonly utilized CAM therapies which include acupuncture, massage, meditation, intravenous 
vitamin C, and chiropractic care (see Appendix D).  
At the suggestion of the Oncology Fellow, a definition of the standard of care was 
provided on Why I want to use CAM. For the purposes of the workbook and CAM therapies, 
OCCAM defined standard of care as those therapies practiced or observed in Western countries. 
The question order was also changed on Why I want to use CAM to better capture the 
information most pertinent for healthcare providers. On the revised form, the order of questions 
two and three was reversed; patients were asked to consider the side effects they wanted to 
relieve through CAM use and then indicate the specific CAM therapies they would like to try. 
Lastly, due to survivor preference version A of Why I want to use CAM was selected as the final 
version of the worksheet (see Appendix B, Figure 1). Prior to the second round of pretesting all 
of the images on version A were replaced with more easily identifiable CAM therapies.  
Some of the tips for talking to your provider about CAM were revised. More neutral, 
non-accusatory language was implemented for some of the tips to prevent alienation of 
healthcare providers. As suggested by the social worker, an additional tip was included on Tips 
for talking to your provider about CAM, with regard to addressing a potential negative 
interaction with a provider. This tip reminds patients that obtaining a second opinion is always 
within their rights. Additionally, all of the tips were reorganized to reflect a logical and temporal 
flow beginning with preparations for an office visit.  
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A common concern stated by both healthcare providers and survivors was that there was 
not enough room to track medications within the medication log. To address this concern, the 
columns “dose” and “frequency and time(s) of day taken” were collapsed into one column, 
which created of some additional space within each row and column. Within the new dose and 
time column, examples were provided for each category of dosing amounts and time of day 
taken. Although the amount of space within each block was still not ideal, the column height and 
row width were increased as much as possible, to keep information about all types of 
medications on one sheet of paper. Additionally, a second sheet to track all medications was 
created to be included within the workbook.  
On the weekly CAM use log, nearly everyone surveyed preferred to have the days of the 
week listed within the first column (see Appendix B, Figure 3). Since the term “conventional 
therapy” was confusing to some survivors, it was replaced with “standard treatment.” However, 
the term “conventional” was retained to describe providers elsewhere within the workbook. 
Additionally, the title of the last column was changed from “how did it make you feel” to 
“notes.” The examples provided on this page were also changed to reflect an exercise-based 
CAM therapy, walking, and a nutritional therapy, ginger pills, to provide users with examples of 
how to document exercise as well as supplementation. Also, because some participants felt 
documenting CAM therapies on a weekly basis might be too taxing during the active course of 
cancer treatments, a monthly CAM use log was created. This log contains the same information 
as the weekly CAM log, date, CAM therapy used, how much or how long, and a notes field, but 
allows the user to track as few or as many CAM therapies as they use each day or week.  
Several changes were made to the glossary as well as the resource page. The glossary was 
reorganized into medication-related terms and CAM categories. The resource page was 
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restructured to cluster the NCI-specific resources together and each description of the additional 
government sources for CAM information was made as simple as possible.  
The cover design was also changed for the workbook as a result of pretesting. Due to 
patient preference, an orange NCI banner bar was placed on the left hand column of the 
workbook, per the NCI graphic design guidelines. Additionally, a small office banner bar was 
placed at the top of the cover page. During testing, one patient suggested the number of images 
on the cover be reduced from six to four. Five images depicting CAM therapies and patient-
provider interactions were selected for the cover; these images feature identifiable mainstream 
CAM therapies as well as images of healthy, smiling people. Because no consensus was reached 
about use of the terms “workbook” versus “guide,” OCCAM made the final decision to call the 
resource a workbook because a majority of the pages require some form of patient interaction. 
Additionally, the phrase Talking about Complementary and Alternative Medicine with Health 
Care Providers: A Workbook and Tips was chosen for the title to complement OCCAM’s prior 
patient education resource, Thinking About Complementary and Alternative Medicine: A Guide 
for People With Cancer. 
Other stylistic changes made to the workbook included changing the color palette and 
header images. The original color palette for the workbook consisted of cool colors. Patients 
surveyed did not dislike the cool palette, but the palette was changed to reflect the selection of 
the orange banner bar for the cover. The orange color was pulled throughout the workbook and 
counterbalanced by a selection of warm and cool colors. The black and white yoga image from 
the front cover was also incorporated throughout the workbook pages by including it in the 
header. The original header images included a picture of vegetables, a yoga image, and a picture 
of multicolored pills. A photo of a tea set replaced the image of the pills. 
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Lastly, wherever possible the sentence structure and instructions were simplified to 
increase reading comprehension. Even after restructuring and reducing sentence length, most of 
the documents included within the workbook have a Flesch-Kincaid Reading Score of 12.0. This 
is in part because the medical terminology used throughout the workbook does not have 
simplified versions or descriptors; for example, there are no other terms or ways to describe 
“chemotherapy.”  
 
4.4 PRETESTING: ROUND TWO 
4.4.1 Patient Population Feedback 
By September 2012, OCCAM was ready to test a second version of the patient education 
workbook with patients and providers. OCCAM was unable to perform another round of Open 
Call Testing because the September session was for Spanish initiatives only. Therefore, OCCAM 
needed to resort to a different method for surveying cancer patients and survivors. NCI’s Office 
of Advocacy Research (OAR) manages the Consumer Advocates in Research and Related 
Activities (CARRA) program, which is comprised of consumer advocates from across the nation 
who voluntarily provide assistance to NCI in the development of various projects. These 
members represent the voice of the cancer community in the roles of survivors, caregivers, and 
advocates.56 With assistance from Shea Buckman Manley OCCAM contacted OAR to acquire a 
list of cancer advocates to review OCCAM’s draft material. By using OAR’s CARRA advocates, 
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OCCAM was able to circumvent OMB clearance requirements via the Paperwork Reduction 
Act.54 
“Cold call” emails were sent to each of the 13 identified CARRA advocates. Each respondent 
was asked to review OCCAM’s workbook and consider the following points of consideration: 
• How would a resource that encourages you to talk to your healthcare providers about 
your CAM use be useful to you?  
• Based on your experience, do you think this workbook would be helpful to patients?  
• Would you recommend this resource to other people?  
• Identify the person or persons within the clinical setting who you think would be most 
likely to refer you to a reference such as this.  
• Describe how keeping track of your CAM use through the forms included in this 
workbook would help you to talk to your doctor about CAM. 
• Describe changes you would suggest to make the resource more useful to you.  
 
Each participant was provided with the same feedback tracking form as the healthcare providers 
to record their answers (Appendix B, Figure 7). Participants were asked to return their responses 
within two weeks of receipt of the email.  
As in the first round of pretesting, the cancer advocates represented a variety of cancer 
types, including bladder, breast, lung, brain, and leukemia; and females were overrepresented. Of 
the 13 advocates contacted, 10 responded. No follow-up efforts were made to contact the three 
advocates who did not respond to the initial email request because of the voluntary nature of 
their services. Included among the advocates were representatives of several major cancer 
advocacy groups, including the American Cancer Society, the Leukemia and Lymphoma 
Society, Friend for Life Cancer Support Network, the National LGBT Cancer Network, and the 
Oklahoma Brain Tumor Foundation. The only demographic data requested of each participant 
was an identification of whether they were a caregiver or survivor. Of the people surveyed, three 
people identified themselves as cancer survivors and seven classified themselves caregivers. No 
additional demographic information was collected from the participants.  
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 All 10 participants who reviewed the workbook found it to be useful and would 
recommend the resource to other people. Several advocates were impressed by the functionality 
of the workbook, specifically the workbook’s encouragement for patients to organize their 
thoughts about CAM use and their treatment options. When asked to consider whether 
OCCAM’s workbook would enhance communication between providers and patients, all 
participants felt it would strengthen the fragmented lines of communication in oncology care. 
Many participants discussed some of the observed patterns of nondisclosure discussed in the 
literature including a “fear of physician response,” a lack of “physician initiation” of CAM 
conversations, and a lack of “understanding” about the “impact of CAM on treatments.” Of the 
participants who recognized the importance of CAM disclosure to healthcare providers, all felt 
OCCAM’s workbook would empower patients to “feel more comfortable,” and “organize their 
thoughts” to discuss CAM with their “medical team.” 
Participants were asked to identify the healthcare providers who would be most likely to 
refer patients to this resource. Providers identified included patient navigators, case managers, 
social workers, nutritionists, nurses, nurse navigators, nurse practitioners (NP) and physician 
assistants (PA), oncology nurses, and pharmacists. Of the nine people who responded to this 
particular question, three people believed some physicians might recommend or guide patients to 
this resource as well. Even though several different types of clinical and ancillary professionals 
were named, one advocate was convinced she would not receive this type of resource in the 
clinical environment due to dismissive reactions of her healthcare providers to use of CAM 
therapies. 
Without having been provided a description of the medium for dissemination, two 
participants emphasized that the workbook should be available in an electronic format, which 
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would allow for continual updating. To increase the utility of the workbook, several respondents 
recommended incorporating the workbook, or select pages from the workbook, into the patient 
record. Integrating the information from the workbook into the medical record would allow all 
physicians and nurses to access important patient information. Even without incorporation into a 
patient’s medical records, several participants believed the information captured would still be 
helpful for healthcare providers because it describes patients’ “overarching view of their whole-
body treatment regime.” Finally, one advocate noted the limited availability of CAM information 
resources for patients. OCCAM’s contribution to the development of patient education resources 
on CAM serves to “improve understanding” of CAM and emphasizes the necessity of patient-
provider conversations about CAM use. 
4.4.2 Healthcare Provider Feedback  
The healthcare providers solicited for feedback during the second round of pretesting were 
professional contacts of OCCAM Director Dr. Jeffrey D. White and Case Review and Intramural 
Science Program Director, Dr. Farah Zia. Dr. Zia, a medical oncologist who divides her time 
between OCCAM and the Clinical Center, identified three staff members, two nurse practitioners 
and a fellow M.D., within her clinical working group to provide feedback. Both nurse 
practitioners provided feedback; however, the oncologist could not be reached for comments. 
Three attempts, including email reminders, were sent to the oncologist, but efforts were 
abandoned after no emails were answered. As in the first round of pretesting, each healthcare 
practitioner was asked to review both the workbook as well as the list of questions and 
comments, discussed previously (see Appendix B.1.5 and Figure 7). The two Clinical Center 
NPs did not have any suggestions for changes to the text or layout of the workbook, and both 
 57 
believed OCCAM’s workbook would be a useful resource for patients. A concern of both of the 
NPs was the amount of space available to describe medications within the medication list, an 
issue that had been discussed extensively by both healthcare providers and survivors during the 
first round of pretesting. Despite the strict protocols for patients seen at the Clinical Center, one 
of the nurse practitioners noted that patients keeping track of their CAM use in logs would be 
helpful, particularly in “clinical trials,” to monitor patient’s CAM use for exclusionary 
treatments, supplements, or regimens. 
 While Dr. Zia provided professional contacts within the NIH, Dr. White identified 
several professional contacts in outside hospital systems, including a NP at Johns Hopkins 
Kimmel Cancer Center and a medical oncologist who practices at Oncology/Hematology of 
Loudon and Reston. Overall, the comments from the NP were very supportive of OCCAM’s 
endeavor. The NP emphasized it is “critical” for healthcare provider to learn of all the 
medications patients taking, including nutritional supplements, to minimize the risks associated 
with drug interactions. The oncologist merely stated the workbook looked good, without 
elaborating on any changes that should be made or the utility of the workbook. 
 In an effort to obtain additional feedback from healthcare providers, Dr. White suggested 
the author present the project to the NCI Physician Data Query (PDQ)® CAM editorial board, 
which is comprised of experts in the fields of oncology, pharmacology, natural products, drug 
discovery and development, traditional Chinese medicine, acupuncture, and homeopathy.57 After 
the presentation to the editorial board on September 21, 2012, follow-up emails requesting 
feedback were sent to each of the 18 board members: of the 18 members, four responded. 
However, two of the respondents were not healthcare providers and therefore, their comments 
were not utilized; the remaining respondents were a registered dietitian and an integrative 
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oncologist. While the registered dietitian stated she would recommend OCCAM’s workbook to 
patients, she emphasized she would do so with hesitation because of the potentially dangerous 
drug interactions with nutritional supplements during the “active” phases of treatment. The 
integrative oncologist also expressed a hesitation to refer patients to this resource because most 
of the information that would be derived from use of this workbook was acquired through his 
interactions with his patients; however, he believed it would be useful for conventional 
oncologists.  
4.5 CHANGES IMPLEMENTED AFTER ROUND TWO OF PRETESTING 
The second round of pretesting did not yield as many edits as the first round of pretesting. 
Pretesting efforts were stopped once a point of saturation occurred in the comments provided by 
healthcare providers and survivors. A majority of the changes made to the workbook were 
concentrated on stylistic elements and included numbering each page of the workbook, 
identifying and keeping a consistent format throughout the glossary for defining terminology and 
the associated examples, changing the title of Understanding cancer CAM terminology to 
Understanding cancer CAM, and incorporating the use of the term “healthcare providers” versus 
“doctors” throughout the workbook, including the cover. The only major textual change to the 
workbook was the incorporation of general CAM education and a statement about potential 
herb/drug interactions on Understanding cancer CAM.  
Additional changes included replacing several of the images on the cover and Why I want 
to use CAM. These images depict people from a variety of ethnic backgrounds and ages and also 
feature a variety of easily identifiable CAM therapies. 
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4.6 SUMMATION OF PRETESTING RESULTS  
Through two rounds of testing, OCCAM was able to obtain feedback from 42 individuals of the 
88 individuals who were solicited for feedback (see Appendix C, Table 2). These individuals 
included patients currently undergoing treatment, survivors, caregivers, staff of major cancer 
advocacy groups, physicians, nurse practitioners, nurses, registered dieticians, and social 
workers. In total, five contractors or general members of the public were solicited for their 
feedback, and therefore did not require additional OMB clearance because OCCAM stayed 
within the parameters of surveying nine or fewer members of the general public. Healthcare 
providers who work for the federal government and are employed by the NIH’s Clinical Center 
represented a convenience sample for OCCAM’s pretesting initiatives (see Appendix C, Table 
3). These individuals are overrepresented because they were easier to solicit for their feedback 
since clearance was not required to speak with federal employees.  
  
4.7 WORKBOOK DESIGN 
Talking about Complementary and Alternative Medicine with Health Care Providers: A 
Workbook and Tips is an interactive workbook designed to increase patient confidence to discuss 
CAM use both during and after cancer treatment with their healthcare providers. This workbook 
consists of informational pages about CAM as well as several documents to track CAM use (see 
Appendix D). The workbook pages include How to use this workbook; Understanding cancer 
CAM; Why I want to use CAM; Tips for talking to your provider about CAM use; My monthly 
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CAM use; My complete medicine list; Members of my health care team; Glossary; and Cancer 
CAM Resources.  
The cover of the workbook features images of several different types of CAM therapies 
and modalities as well as interactions between patients and healthcare providers. A wide variety 
of ages and ethnicities are depicted in the selected photos. The cover design features images and 
color blocks displayed in a grid-like fashion. The combination of the gridlines and the color 
blocks provides sections of white space for the eye to rest and also reduces the amount of clutter 
on the cover. During Open Call Testing, participants favored two of the images selected for the 
cover, the woman in a yoga position and barrels of spices. Another design feature of the cover is 
the interplay between warm and cool colors, which provides an overall calm appearance for the 
cover. 
How to use this workbook is the first page of the workbook and introduces the reader to 
the content of the booklet and the importance of discussing CAM therapies with healthcare 
providers. Instructions are provided for both patients and healthcare providers about how to 
utilize the worksheets included.  
Understanding cancer CAM provides a list of definitions for commonly used terms to 
describe CAM, including “complementary medicine,” “alternative medicine,” “complementary 
and alternative medicine,” and “integrative medicine.” Unfortunately, as previously discussed, 
there is no standardized way to describe complementary and alternative medicine, and the 
application of these terms varies between institutions as well, further complicating 
comprehension of CAM. As an example, the National Cancer Institute uses the term 
“complementary and alternative medicine” throughout its publications while the M.D. Anderson 
Cancer Center prefers the term “integrative” in its descriptions and promotion of CAM therapies. 
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Understanding cancer CAM also features common reasons why people seek CAM therapies and 
a list of CAM therapies. 
Why I want to use CAM encourages patients to think about their motivations for CAM 
use, why they want to use CAM, what side effects they want to alleviate through CAM, and what 
therapies intrigue them. This sheet is meant for patients to complete prior to a doctor’s 
appointment to help organize their thoughts about CAM use. The collaborative Ask 3 campaign 
of the National Patient Safety Foundation and the American Medical Association was used as a 
proxy for question development on this document.58 The Ask 3 initiative encourages patients to 
discuss three main questions with their provider: 1) What is my main problem? 2) What do I 
need to do?, and 3) Why is it important for me to do this?58 Modifications to these questions 
were made to reflect information that would help oncology and primary care providers 
understand motivations for CAM use, while maintaining the integrity of the information obtained 
from these questions. Review of these questions not only empowers patients to speak with their 
healthcare provider about their CAM use, but also provides an avenue for patients to discuss any 
symptoms or side effects of treatment that are not being managed through conventional 
therapies. This sheet can be either handed to the physician to review or used as an aid to guide 
the conversation.  
The next sheet in the booklet, Tips for talking to your provider about CAM use, provides 
patients with guidelines for engaging in CAM conversations with their providers. Eleven tips are 
presented and organized into three categories to provide guidance and empowerment at various 
stages of patient-provider interactions. These suggestions involve simple strategies patients can 
employ prior to and during their consultations with healthcare providers to enhance discussions 
about both CAM use and their treatment plan. A majority of the tips provided were adapted from 
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guidelines provided by several advocacy organizations and government resources including the 
American Cancer Society, the Leukemia and Lymphoma Society, BreastCancer.org, the 
Canadian Cancer Society, Susan G. Komen for the Cure, NCCAM, the NCI PDQ® Cancer 
Information Summary: Pain, and the NCI PDQ® Cancer Information Summary: Communication 
in Cancer Care. The tips, while rewritten and adapted for CAM-specific use, encourage patients 
to be proactive, document their concerns and questions, and request additional time, 
appointments, or resources when necessary.  
My monthly CAM use asks patients to track their CAM and its effect(s) on symptom 
abatement over the course of a month, noting the length of time a therapy was performed (e.g., 
30 minutes of yoga) or quantity that was used (e.g., 2 cups of green tea). As Schumacher et al.59 
observed, tracking symptoms via health diaries enables patients to observe trends in their own 
behavior as well as trends in their own symptom management, pain, and symptom alleviation. 
For healthcare providers, tracking CAM use over the course of a month provides cross-sectional 
data about the self-care strategies patients employ to manage their care outside of the clinical 
environment.  
My complete medicine list asks patients to think about all of the medicines they currently 
use, including herbs, dietary supplements, and vitamins. OCCAM’s medication list was adopted 
from the American Cancer Society’s Medicine List, which encourages patients to keep track of 
their medicines regardless of class of medication. The ACS Medicine List is not separated into 
prescription medications, OTC medications, and nutritional supplements. Only a small note, 
located at the bottom of the sheet, instructs patients to document their supplement use.  
Since patients neglect to tell their providers about supplements they use in addition to 
prescription medications, it was imperative for OCCAM’s worksheet to separated medicines into 
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three categories: prescription; OTC; and herbs, vitamins and dietary supplements. 
Documentation of all types of medications cancer patients use is particularly important because 
of the propensity of cancer patients to utilize nutritional supplements and the fact that cancer 
patients may have comorbidities, for which medication effectiveness may be decreased through 
use of supplements. For example, Echinacea, an herbal supplement often touted to improve 
immune function, interferes with the chemotherapy drugs methotrexate and ketoconazole.53 
Another common herbal supplement, ginkgo, is not recommended for people who take aspirin, 
non-steroidal, anti-inflammatory drugs, such as ibuprofen, or anticoagulants, such as heparin, 
due to an increased risk of bleeding.13,53 Vitamin B6 when taken with altretamine, an 
antineoplastic used to treat ovarian cancer, decreases the drug’s effectiveness.13 Finally, St. 
John’s wort, an herbal supplement often taken to suppress mild to moderate depression, has been 
shown to interfere with warfarin, (Coumadin), an anticoagulant which is sometimes prescribed 
for cancer patients who may present a risk of developing of blood clots from their 
chemotherapeutic treatments or have cardiovascular comorbidities. 13,53 
Members of my health care team gives patients a space to organize the contact 
information for their conventional and complementary providers.  This sheet may be valuable for 
personal use or and can be shared with healthcare providers to foster coordination of care 
between conventional and complementary providers.   
The Glossary provides definitions of medicine-related terms used throughout the patient 
education booklet. In addition, it describes the categories of CAM therapies that governmental 
organizations use.  
Finally, the Cancer CAM resources page lists additional resources for patients and 
healthcare professionals to learn more about CAM therapies.  There are no private organizations 
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supported in this document due to governmental restrictions on private endorsements. However, 
all of the sites listed provide evidence-based information and include the FDA, Office of Dietary 
Supplements (ODS), NCCAM, and other NCI resources. 
 
4.8 WORKBOOK RATIONALE 
From the environmental scan that was performed, it was determined any education material 
created should provide cancer patients with tangible materials to empower them to engage in 
conversations with their healthcare providers about use of CAM. With so few patient education 
resources dedicated to fostering effective communication about CAM use, OCCAM pursued the 
development of a patient education resource surrounding this very topic. Traditionally strategies 
to engage in CAM conversations with healthcare providers have been characteristically 
presented as lists, as demonstrated through the environmental scan, and while they highlight the 
importance of CAM conversations, they do not inherently motivate a patient to initiate such 
conversations. Increasing a patient’s self-efficacy is a central component of the design of the 
workbook, particularly because one of the reasons cancer patients seek CAM therapies is to 
regain a sense of control over their cancer diagnosis. This workbook strives to help patients 
regain a sense of control over their conversations with their doctors and healthcare providers, in 
an effort to communicate their goals, expectations, and needs associated with the physical, 
mental, and spiritual aspects of cancer care. A workbook format enables patients to take 
proactive roles in their health dialogues by organizing and documenting their CAM use, rather 
than relying on a list of suggested tips for approaching conversations.  
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Due to the size and scope of the target audience, which includes cancer patients, cancer 
survivors, caregivers, family members, healthcare providers, and members of the general public, 
an online communication campaign was chosen as the communication medium. This medium is 
not only cost-effective, but also has the ability to reach the most members of the target audience. 
However, a primary limitation of an online campaign is it does not address the digital divide, and 
therefore ignores an important population that does not have ready access to computers. Another 
limitation is segmentation of the audience by age, sex, race, or cancer type to create tailored 
health communication messages is virtually impossible. The ability to create culturally 
competent material is also restricted. Lastly, the workbook is only available in English, although 
OCCAM may pursue Spanish translation at a future point. To address the issues of segmentation 
and cultural competency, a workbook was created for an adult population using neutral language, 
and every effort was made to select images that represented a diverse group of individuals and 
ages. Even though it is hypothesized that patients will be more likely to use this resource than 
healthcare providers, the decision to utilize an online medium does not exclude healthcare 
providers from using these resources as well.  
To further expand the reach of the communication initiative, the patient education 
material was designed as a compilation of PDFs, which can be downloaded as a complete 
education workbook or as individual pages. Presenting the communication materials in this 
manner enables the patient to use the resource pages in a way that will be most beneficial to him. 
For example, some individuals may find My complete medicine list most helpful because they do 
not view herbs, vitamins, or dietary supplements as medicine, and other people may find 
downloading the complete booklet more helpful to initiate CAM conversations with their 
healthcare provider(s).  
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Several assumptions are inherent in both the design and utilization of this workbook. One 
assumption is the user possesses a higher degree of health literacy, as there are many complex 
topics discussed within the booklet, including medication compliance, knowledge of medication 
side effects, patient-provider communication, and knowledge about the field of CAM. It is 
recognized that the average health communication material is written at a 10th grade reading 
level, despite the fact that the average American reads at an 8th or 9th grade level.60 However, 
much, if not all, of Talking about Complementary and Alternative Medicine with Health Care 
Providers: A Workbook and Tips is written at a 12th grade reading level due to the medical 
terminology used throughout the workbook. There are no simpler terms for most medical 
treatments used in cancer care including radiation and chemotherapy.  
Another inherent assumption in the design of the workbook is that the user is motivated 
to track symptoms, medications, and CAM use. Lastly, this workbook assumes healthcare 
providers will want to know about the CAM therapies patients utilize and will be receptive to 
talking about CAM. 
Much of the design of the workbook is built on adaptations of different health diaries and 
health-related forms for tracking medical information. Several studies discussed the validity of 
using health diaries for pain management in cancer treatments.61-65 In a 2011 review article, 
Allard and colleagues64 suggested that pain diaries are a promising nursing intervention due to 
their brevity and high compliance rates, which ranged from 60-85%.61,63,66 The American Pain 
Society67 also recommends the use pain diaries to increase patient involvement in their care. As 
clinical interventions, health diaries are generally not perceived as invasive or time-consuming 
by the patients themselves.63,68 When health diaries are used as clinical interventions, patients are 
asked to document their symptoms for two to four weeks at different intervals during the day: 
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however, the length of time of data collection may differ depending on the focus of the 
intervention.69  
One of the strengths of using of a health diary is it enables researchers and clinicians to 
gather a wealth of information from patients70,71 about symptom management, medication 
compliance, and other health behaviors outside of the clinical setting.61,65,68 Health diaries may 
also provide a way for clinicians to derive real-time information about chemical toxicities72 and 
observe fluctuations in pain levels that may occur during and after treatment.68 It also minimizes 
recall bias.68,69,71   
 Through the use of health diaries, a tool successfully used in oncology practice to 
document pain management and patterns,59,61-66,72 patients are able to record their nutritional 
supplement use, note different CAM therapies they have tried over the course of a month, and 
organize contact information for all of their conventional and complementary practitioners. 
Schumacher et al.59 argued that pain diaries help patients recognize the extent of their pain, 
develop proper medication adherence, and notice patterns of pain by tracking behaviors. Through 
documentation of symptoms and associated coping strategies via health diaries patients enhance 
their understanding of their disease and treatment59 and also become more aware of their need for 
assistance.65  
4.9 IMPLEMENTATION OF THE WORKBOOK 
 
As of January 2013, Talking about Complementary and Alternative Medicine with Health Care 
Providers: A Workbook and Tips was finalized. Dissemination of this workbook has begun and 
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promotional strategies to date have used a variety of channels to reach to the intended audiences. 
Nearly every channel that is being utilized or that will be utilized is Internet-based. Even though 
multiple websites, listservs, and social media outlets will be employed for promotion, the 
primary location of the workbook will be on OCCAM’s website (http://cam.cancer.gov). From 
OCCAM’s website, the user will be able to download the entire workbook or the individual 
workbook pages as PDF files for free (see Appendix E, Figure 8). Small screenshots along with 
descriptions of the function and use of each page enable users to easily search for the document 
that will be most beneficial to them without having to download the entire workbook.  
The workbook is also available for download from the NCI Publications Locator, a 
database that allows users to search for NCI publications by using keywords, titles, or 
publication number (see Appendix E, Figure 9). The specific search terms associated with 
OCCAM’s workbook include “complementary medicine,” “alternative medicine,” “integrative 
medicine,” “cancer CAM use,” “CAM,” “patient-provider communication,” “patient education,” 
“communication,” “medication list,” “cancer treatments,” “symptom management,” “dietary 
supplements,” and “supplements.” The NCI Publications Locator contains several of OCCAM’s 
existing publications for download including Thinking About Complementary and Alternative 
Medicine: A Guide for People With Cancer51, NCI CAM News, NCI’s Annual Report on 
Complementary and Alternative Medicine from fiscal years 2005 through 2010, and several other 
pamphlets OCCAM has produced.  
To date, additional promotional activities have involved email outreach via OCCAM’s 
listserv (see Appendix E, Figure 10). OCCAM’s listserv subscribers include healthcare 
providers; CAM researchers; the general public; members of CPEN; patient education 
departments of the NCI-designated Cancer Centers; the Consortium for Academic Health 
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Centers for Integrative Medicine, which is composed of integrative medicine centers or hospitals 
located in the United States, Canada, and Mexico; and various cancer advocacy organizations. In 
addition, the Winter 2013 issue of OCCAM’s newsletter, NCI CAM News, main story discussed 
the development of OCCAM’s initiative, further promoting this resource. Other internal 
promotion of OCCAM’s workbook may be occurring at the NIH’s Clinical Center, but the 
author is not privy to this information.  
Future dissemination strategies could include contacting the CARRA advocates and 
healthcare professionals, who provided feedback on the draft materials, to not only show each 
person the final version, but also encourage them to share this resource. OCCAM could also 
choose to contact the patient education departments of various NCI-designated Cancer Centers to 
encourage integration and promotion of their resource into patient education resources. In their 
contact with various patient education departments, OCCAM could suggest providers distribute 
its resource to patients, as many patients cited they’d expect to receive this resource from their 
doctor.  
Other NCI resources that could be used to promote OCCAM’s initiative include NCI’s 
Facebook and Twitter accounts. Unlike a lot of the offices, divisions, and centers of the NCI, 
OCCAM does not have a presence on social media. The use of social media is important in order 
to increase the outreach and knowledge about OCCAM’s patient education resources, since 
many people use Internet searches and cancer advocacy groups to obtain health information 
instead of governmental resources. By utilizing social media, OCCAM will not only increase 
promotion of the workbook, but also increase awareness about its office and the research it 
supports. On February 5, 2013, OCCAM’s workbook was posted to the NCI’s main Facebook 
page (see Appendix E, Figure 11). The same week it was “shared” by six organizations including 
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the Association of Oncology Social Work, the Oklahoma Health Care Authority, and an 
insurance agency, Insurance Advisors Agency, Inc. (see Appendix E, Figures 12 and 13). 
Another advantage of using social media is the potential to partner with other NIH 
offices, institutes, and centers, thus further expanding the reach of the campaign. Two NIH 
offices and centers with similar campaigns are ODS and NCCAM. ODS has produced a mobile 
app to help people track their dietary supplement use, called My Dietary Supplements or MyDS, 
while NCCAM encourages patients and providers to talk about CAM use through their Time to 
Talk campaign. ODS and NCCAM have a social media presence and could facilitate increased 
dissemination of OCCAM’s workbook through their Twitter accounts, since their audiences 
differ from those of OCCAM. Relative to OCCAM, ODS’s and NCCAM’s target audiences are 
not as specialized and include people with a variety of chronic diseases, acute illnesses, and 
healthy members of the general public in addition to healthcare providers and researchers.  
The marketing strategies for the patient education workbook target a variety of audiences, 
including healthcare providers, cancer patients and survivors, caregivers, and members of the 
general public. Use of multiple methods and channels of dissemination will strengthen the reach 
of OCCAM’s initiative, increasing the likelihood that cancer patients and their healthcare 
providers will utilize this resource. These promotional strategies may also serve to increase the 
brand recognition of OCCAM, since OCCAM is often confused with NCCAM or not recognized 
as an existing office of the NCI.  
Evaluation of the patient education workbook will remain a constant challenge for 
OCCAM because of the medium of the resource. As an Internet-based initiative it will be hard to 
determine the patterns of use for this document. While web analytics will inform the COP staff 
how often the resource is downloaded, it will not show what is done with the resource once it is 
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downloaded. The web analytics also will not be able to decipher artifacts associated with 
downloading, which include accidental downloads. Additionally, the office is limited in its 
ability to survey healthcare providers and patients under the guidelines of the Paperwork 
Reduction Act; any formal surveys to determine how useful the resource is once downloaded 
would require additional funding, official approval, and clearance. 
Even though there are limitations to the feasibility of developing formal evaluation 
strategies, one strategy OCCAM can employ is to request comments from users. A statement 
could be placed at the bottom of the webpage featuring the workbook pages voluntarily asking 
users to email comments or suggestions to COP staff, thus circumventing the guidelines of the 
Paperwork Reduction Act. While not ideal, this method of obtaining feedback on the validity and 
usability of OCCAM’s patient education resource might provide at least some guidelines as to 
how effective this communication initiative is to the public and provide OCCAM with ideas to 
develop additional patient education resources. 
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5.0  DISCUSSION 
During the course of any physician-patient interaction, patients and healthcare providers should 
engage in clear communication with one another and establish and maintain open lines of 
communication, but this is particularly important when patients are thinking about or actively 
using complementary and alternative medicine. By developing effective communication with 
one another, the patient and provider are able to better understand one another’s perspectives, 
and more importantly, the provider is able to recognize some of the patient’s unmet needs. These 
unmet needs may also change throughout the course of treatment, and particularly as patients 
transition into survivorship. Encouraging communication between patients and providers about 
CAM use is necessary in order to reduce medical mistakes,39 increase trust and patient 
satisfaction of providers,21,30,35 and increase medication compliance,21,30,35 all while strengthening 
the model of patient-centered care. Addressing communication issues between patients and 
providers is also important as the prevalence of CAM use continues to grow among the cancer 
patient and survivor communities, in their quest to seek less toxic alternatives to cancer symptom 
management. 11,21,26,30,31   
This paper does not report on the motivations for CAM use among cancer patients and 
survivors or describe the disclosure patterns of CAM use. Instead, this paper focuses on the 
designs used to test the utility of Talking about Complementary and Alternative Medicine with 
Health Care Providers: A Workbook and Tips. It was necessary to review the literature on the 
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prevalence of CAM use among the general population and the cancer population, the patterns of 
CAM use, and the barriers and facilitators of CAM conversations in order to develop an 
understanding of the context of the problem.  
 A review of the literature coupled with pretesting demonstrated that Talking about 
Complementary and Alternative Medicine with Health Care Providers: A Workbook and Tips 
addresses an identified gap in existing resources for patients and providers. Of the patients and 
healthcare providers surveyed, nearly every respondent recognized the importance of discussing 
CAM use. Many participants discussed how their physicians were always asking about what 
types of medication they were taking. During the course of medical encounters, patients expect 
their healthcare providers to ask them questions about their medications, symptoms, and 
behaviors, and OCCAM’s workbook enables patients to better prepare for these questions as well 
as interject their own questions into the health conversations. Both healthcare professionals and 
patients spoke of the important role of documentation in the context of patient-provider 
communications. Through the course of testing, patients described how documentation of 
questions and CAM use would aid them in their conversations with providers, and healthcare 
providers appreciated any supplemental information patients provide during clinical visits.  
Several of the healthcare providers surveyed felt this resource would be helpful for 
patients who expressed an interest in CAM therapies. Many reiterated the importance of knowing 
all medications a patient uses, including vitamins, herbs, and dietary supplements. Nutritional 
supplements are particularly dangerous when not disclosed, because they have an increased 
potential for drug interactions and toxicity with prescription medication, chemotherapeutic 
regimens, and radiation treatments. Unlike prescription drugs, nutritional supplements are not 
required by the FDA to be “approved for their safety and effectiveness before they reach 
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consumers.”73 However, they are monitored for adverse effects once on the market. Most 
healthcare providers identified OCCAM’s initiative as an innovative strategy to aid physicians 
and patients in discussions about the motivations for CAM use. Comments from the advocates, 
caregivers, and patient populations echoed the sentiments of the healthcare providers regarding 
the utility of the workbook; many felt this resource would be useful in their personal records of 
symptom management and recognized the value of documenting medications and CAM 
therapies. 
 A primary objective of OCCAM’s initiative was to increase knowledge about cancer 
CAM.  In addition to educating patients and survivors about the importance of talking to 
healthcare providers about CAM, OCCAM’s workbook seeks to empower patients and survivors 
to initiate these conversations. Embedded throughout the entire workbook are reminders about 
the importance of disclosing CAM use to providers as well as strategies to engage in these 
conversations. By creating action-oriented tasks, OCCAM’s initiative provides an innovative 
solution to addressing the miscommunication about CAM. The current medical climate of 
patient-centered care is based on  “effective communication which forms the basis of patient’s 
understanding of disease and self-management options”(p365).74 This workbook requires users to 
interact with not only the workbook pages, but also with their healthcare provider, creating an 
active two-way conversation about CAM, if the workbook is used as intended. However, even if 
the workbook is not shared with healthcare providers, it still encourages patients to think about 
their motivations for CAM use, including symptoms that are not being properly managed 
through traditional care.  
Another goal of OCCAM’s initiative is to impart patients’ preferences for holistic 
approaches to their health to their healthcare providers.  The workbook helps providers learn 
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patient perceptions about the use of CAM, their preferences for certain CAM therapies, and how 
patients make decisions about which therapies to use. Understanding these motivations for self-
directed CAM or provider-directed CAM is particularly important to establish active and open 
dialogue between patients and healthcare providers.  
One way in which this is accomplished is through the integrated use of health diaries in 
Talking about Complementary and Alternative Medicine with Health Care Providers: A 
Workbook and Tips.  Health diaries are clinical tools that have been used to monitor a variety of 
conditions and behaviors. Some of the more popular adaptions of health diaries include sleep 
logs, exercise logs, and food diaries. These clinical interventions have also been prominently 
used within oncology to track and monitor pain. As clinical interventions, health diaries are 
generally not perceived as invasive or time-consuming by the patients themselves,63,68  and they 
allow clinicians to acquire information about symptom management, medication compliance, 
and other health behaviors outside of the clinical setting.61,65,69 Furthermore, they enable patients 
to increase their understanding of their disease and treatment59 as well as their need for 
assistance.65  
 OCCAM’s initiative is an important first step in bridging the communication gap 
between cancer patients and survivors and healthcare providers and is embedded with several 
important public health principles. The development of OCCAM’s workbook was not designed 
to address any Healthy People 2020 goals specifically, but it was determined that this workbook 
contributes to the work of at least two of the Healthy People 2020 Health Communication and 
Health Information Technology goals. Healthy People 2020 is a set of 10-year national 
objectives designed to improve the health of the nation. These objectives seek to identify and 
reduce the burden of disease, reduce health disparities and health inequalities, and promote the 
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health and wellness of the country.  The specific Healthy People 2020 objectives75 that 
OCCAM’s workbook works towards are: 
HC/HIT-3: Increase the proportion of persons who report that their healthcare providers 
always involved them in decisions about their healthcare as much as they wanted. 
 
HC/HIT-4: Increase the proportion of patients whose doctor recommends personalized 
health information resources to help them manage their health. 
 
OCCAM’s workbook facilitates greater participation of patients in health conversations by 
providing them with resources to feel more supported to initiate CAM conversations with their 
providers. This is accomplished through the use of pages to document CAM, including 
motivations for CAM use, frequency and type of CAM used, and all medications used in care 
management, and informational pages that provide patients with strategies on how to engage in 
health conversations and sources of additional information. Documentation of CAM, whether 
self-selected or provider-directed, permits members of the healthcare team to understand 
patients’ beliefs allowing for greater personalization of care plans. This workbook also addresses 
one of the core functions of public health: to inform, educate, and empower people about health 
issues.76 
OCCAM’s development of a patient education workbook represents an effort to improve 
the dialogue between cancer patients, survivors, and healthcare providers about CAM. Future 
communication campaigns should focus on the development of mobile applications (apps) to 
track CAM use. Rather than develop a cancer CAM-specific app to track CAM use, 
communication initiatives should attempt to integrate CAM tracking into already existing 
medical tracking apps. Integration of medications, questions, and appointments may foster better 
documentation of behaviors and streamline the information available for both patients and 
healthcare providers. In an increasingly mobile society, packaging all of this information 
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together in one location may prove to be extremely useful.  These strategies will allow users to 
access their medication lists and CAM use at any point in time and without having to rely on 
their memory to bring paper versions of this documented information with them to doctor’s 
appointments. Development of a mobile app to track CAM use may result in greater assessment 
of CAM use among minorities since 44% of Blacks and Latinos are smartphone users.77 
Additionally, a CAM app may result in greater CAM-tracking behaviors among adults 25-44, as 
58% of Americans between the age of 25 to 34 and 44% of adults 35-44 own smartphones.77 
Further research on the development of CAM tracking apps may indicate that the 
aforementioned groups, younger individuals and minorities, prefer to record their CAM use via  
mobile apps than on online PDFs or paper tracking forms.  
Future research on the patterns of CAM use among cancer patients and survivors should 
focus on why disclosure rates of CAM use remain so low, despite changing patterns of 
acceptance and use of CAM therapies by traditional medicine. Additional research is also needed 
to determine the types of educational resources healthcare providers want to increase their 
knowledge about CAM. This research should also include strategies to get more healthcare 
providers to initiate CAM conversations.  
Coupled with increased research efforts, greater public awareness campaigns should be 
created to educate patients and the general public about provider knowledge of CAM therapies.  
Consumers of CAM need to recognize the evolutionary nature of the field and that it remains 
impossible for healthcare providers to stay abreast on all of the various remedies, supplements, 
and therapies. The field of CAM is ever-evolving and there is much work to be done in order to 
create evidence-based knowledge of the effects of CAM therapies on the body and clinical 
treatments. What remains imperative throughout this iterative process is the need for active and 
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6.0  CONCLUSION 
6.1 THESIS SUMMARY 
Many patients utilize CAM during or after a cancer diagnosis as a way to regain a sense of 
control over a health condition that makes many cancer patients feel powerless. 11,12,21,28,31,33-36 
Other motivations for CAM use include managing side effects, 11,21,28,30-32 preventing secondary 
or recurring cancers, 30,33 and boosting the immune system11,21,28,30,33 and enhancing one’s quality 
of life. 11,21,28,30,31,33,34 Often the therapies that are chosen are self-selected and not disclosed to 
healthcare providers.  
Despite a high prevalence of CAM use among cancer patients and survivors, use of these 
therapies is often not disclosed to healthcare providers. Patients are often fearful of their 
healthcare providers’ reaction to CAM use,12,31,33,35,39 underestimate a physician’s knowledge and 
comfort discussing CAM,12,30,35 are unaware that CAM therapies can adversely affect their 
treatments, 12,21 and are simply not asked by their healthcare providers about CAM use. 12,31 
Furthermore, when patients want to discuss CAM, it is often up to them to initiate the 
conversation.41,43,44  
Talking about Complementary and Alternative Medicine with Health Care Providers: A 
Workbook and Tips was developed to address the miscommunication between cancer patients 
and healthcare providers about CAM. Several studies have demonstrated CAM use is high 
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among cancer patients and survivors.10,25-28 To develop OCCAM’s workbook, several of 
OCCAM’s existing sources of qualitative data were reviewed, including public comment 
responses and focus group transcripts. Review of these data revealed the major reasons why 
patients utilize CAM therapies as well as their information-seeking behaviors. An environmental 
scan was performed of 18 different cancer advocacy groups to determine how CAM is presented 
and what communication mediums are frequently used. Nearly every website surveyed stressed 
the importance of disclosing CAM use to one’s healthcare provider. Finally, a literature review 
was conducted to understand the current research on the barriers and facilitators associated with 
patient-provider communication of CAM.  
 Talking about Complementary and Alternative Medicine with Health Care Providers: A 
Workbook and Tips was designed to complement OCCAM’s existing patient education resource, 
Thinking About Complementary and Alternative Medicine: A Guide for People With Cancer. 
While the workbook was not designed using any form of theoretical framework, looking at the 
two resources together, it is apparent these efforts reflect an adaptation of the TransTheoretical 
Model.78 
In considering the posited constructs of the TransTheoretical Model, Thinking About 
Complementary and Alternative Medicine: A Guide for People With Cancer provides an 
overview of CAM including questions to ask doctors about CAM, strategies on how to choose 
CAM therapies and practitioners, and additional resources for more CAM information and would 
be appropriate for those in precontemplation or contemplation stage of CAM use. The format of 
Talking about Complementary and Alternative Medicine with Health Care Providers: A 
Workbook and Tips, however, would be considered appropriate to help patients in the 
preparation, action, or maintenance stage, who are already familiar with CAM therapies and 
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those who have integrated CAM into their treatment strategies. Together these resources 
encourage patients and providers to communicate about complementary and alternative medicine 
use both during and after cancer treatments and recognize the importance of involving patients as 
active participants in decisions about their treatment plans in order to increase their self-efficacy. 
To help bridge the communication gap between patients and providers, OCCAM 
developed an interactive patient education workbook designed to document CAM use and to 
empower patients to engage in CAM conversations with their providers. To the best of 
OCCAM’s knowledge, this is the first interactive CAM workbook for cancer patients and 
survivors. The 15-page workbook is comprised of informational sheets and health diaries, to 
encourage patients to record their nutritional supplement use, note different CAM therapies 
they’ve tried, and document their motivations for CAM use. The workbook design revolves 
around the use of health diaries because of the success seen in the use of health diaries in 
oncology practice to document pain management and patterns.59,61-65,66,72 Health diaries provide 
an easy method to capture patient behaviors outside of the clinical environment and have the 
potential to be integrated into a patient’s medical record.  
 Two rounds of pretesting were conducted among cancer patients, survivors, caregivers, 
cancer advocates, and healthcare professionals. Pretesting was conducted to evaluate the design 
of the workbook and to determine the usability and functionality of the workbook. Through each 
round of pretesting, the workbook was improved based on the suggestions made by healthcare 
providers and cancer survivors. The overall response to OCCAM’s initiative was quite favorable, 
as most of the survivors and healthcare providers believed OCCAM’s workbook would aid 
conversations about CAM. Of the worksheets included in the workbook, My complete medicine 
list was the most popular sheet among survivors and healthcare providers.  
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6.2 STRENGTHS AND LIMITATIONS 
There are several limitations of this project. Talking about Complementary and Alternative 
Medicine with Health Care Providers: A Workbook and Tips was designed for a national 
audience. It is limited in its ability to target the communication messages to any particular group 
or develop culturally competent messages. Another limitation of the workbook is the 
communication medium that was chosen. By choosing an online format for its communication 
initiative, OCCAM does not address the issue of the digital divide. Furthermore, while cancer 
patients gravitate towards online sources for information, tracking CAM use via OCCAM’s 
workbook requires the user to either download the workbook and fill in the information on one’s 
computer or fill in the information by hand. This increases the burden on the individual to 
accurately capture his use of CAM therapies and to remember to bring this information with him 
to his doctors’ appointments. A preferable method to track CAM use may be through the use of a 
mobile app, such as ODS’ MyDS app, allowing the user to retrieve this information or add 
entries at any point in time. Finally, the choice of an online medium, which requires the user to 
download either the workbook or an individual worksheet from OCCAM’s website, renders 
OCCAM powerless to determine the effect of its initiative.  
The data used during the formative research process also present another limitation of the 
workbook. The focus group transcripts, which were used to understand patient’s motivations for 
CAM use, were collected over 10 years ago. These data may not be reflective of current needs 
and motivations for CAM use among cancer patients and survivors, particularly as trends 
associated with CAM use have continued to increase.  
The sample sizes obtained for each round of pretesting is also a limitation. Twelve cancer 
patients and survivors and an additional 30 healthcare providers, advocates, and caregivers were 
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asked to provide input on OCCAM’s workbook. By no means is either sample representative of 
the populations of cancer survivors, caregivers, or healthcare providers. In fact, the sampling 
strategy employed to garner feedback was a convenience sample. The trends observed from the 
two rounds of pretesting indicate OCCAM’s workbook might improve CAM conversations, 
however, without a representative sample of cancer patients, cancer survivors, caregivers, and 
healthcare provider generalizations cannot be made about the workbooks impact. In order for 
generalizations to be made, a larger, more representative sample of cancer survivors and 
healthcare providers would need to be obtained.  
Another limitation of OCCAM’s pretesting efforts was that key groups of healthcare 
providers, including pharmacists, could not be identified to provide feedback on the workbook. 
Among those who were surveyed, healthcare providers at the NIH’s Clinical Center were 
oversampled because surveying federal employees does not require OMB clearance. 
Additionally, the comments provided by these doctors, nurse practitioners, and social workers 
may be different from those obtained from healthcare providers working in public or private 
hospital systems or practices. Patients who are seen or admitted to the NIH Clinical Center are 
enrolled in clinical trials and must adhere to the guidelines and protocols of the clinical trial, thus 
reducing their use of CAM therapies.  
A final limitation of the workbook is lack of an evaluation plan for dissemination of the 
workbook. Evaluation is a necessary step in the process of the development of any public health 
resource, whether it is a program or a patient education resource. Future critiques of OCCAM’s 
workbook will likely require the use of an external evaluation and should be coordinated with 
NCI-designated Cancer Centers, university hospitals, and physician’s offices to determine the 
effectiveness of the materials.  
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There are several limitations of this workbook, but there are also several strengths 
associated in the design of the workbook. Much of the discussion of this thesis has focused on 
the use of OCCAM’s workbook for either cancer patients or survivors, but patients enrolled in 
palliative treatments, with no hope for a cure, may also find this workbook helpful. These 
patients may seek CAM as a way to retain a sense of hope11,21,34 and increase their quality of 
life11,21,28,30,31,33,34 when conventional treatments have failed. It should be noted that palliative 
treatments are not only administered when a cure is not possible, but may also be administered in 
conjunction with conventional treatments. Therefore, workbook as designed can be used at any 
stage of a cancer diagnosis, with patients in active treatment, active surveillance, palliative 
treatment, with no cure, or survivorship able to use this resource to engage in CAM 
conversations with their providers.   
While the focus of this workbook was to improve CAM conversations among those 
diagnosed with cancer and their healthcare providers, people who have additional chronic 
diseases, other than cancer, can also utilize this workbook. As previously discussed, adults use 
CAM to help manage a variety of chronic diseases including neck pain, back pain, arthritis, 
anxiety, head and chest colds, depression, and headaches.15-17 In a cross-sectional survey of CAM 
use among adults with chronic disease, Saydah et al.22 found individuals diagnosed with arthritis 
to be the highest CAM consumers. The neutral language embedded within OCCAM’s workbook 
and limited discussions of cancer, allow the workbook to be used by other chronic disease 
populations. This workbook may foster greater discussion of CAM with healthcare providers, 
including specialists or general internists. Lastly, the design of the workbook and availability to 
download individual workbook pages encourages use by members of the general public as well.  
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Other strengths of OCCAM’s initiative include the widespread dissemination to anyone 
with computer access, the free usage and the capability to download multiple copies of the 
workbook, and the availability of the workbook to be used by healthcare providers, patients, and 
members of the general public. OCCAM’s workbook also supplements existing CAM resources 
and highlights the importance of discussing and disclosing CAM use within health 
conversations. Finally, the design allows for the individual to tailor use of the resource to his/her 
needs, with the capability of downloading individual worksheets or the entire workbook.  
6.3 RECOMMENDATIONS 
Prior to or after dissemination, a small pilot test should be conducted with patients in active 
treatment to assess the design, functionality, and usability of the workbook. Due to governmental 
sampling limitations and funding constraints, a convenience sample of patients at the NIH 
Clinical Center is suggested and should include a brief survey in addition to patient 
documentation of their CAM use. A self-administered or interviewer-administered survey could 
ask patients to identify how the workbook helped facilitate discussions of CAM use with their 
providers and probe on what aspects of the workbook were most and least useful.  
Other efforts to enhance patient-provider communication about cancer complementary 
and alternative medicine use should include developing health communication campaigns 
targeted at healthcare providers. Although Talking about Complementary and Alternative 
Medicine with Health Care Providers: A Workbook and Tips was designed for both patients and 
providers, it is expected that patients will find this resource more helpful than providers. Several 
of the providers surveyed through the pretesting efforts indicated a need for educational 
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resources aimed at increasing healthcare providers’ knowledge and awareness of the use of CAM 
therapies. Resources should be designed to help healthcare providers understand the scientific 
evidence supporting CAM use, patient motivations to use CAM, and establish guidelines for 
engaging in conversations with patients about CAM. 
One possible avenue to increase physician awareness about CAM would be for OCCAM 
to develop a curriculum of continuing medical education (CME) credits for physicians, in the 
form of modules, webinars, presentations or journal articles. One possible avenue for this would 
be to develop a webinar for NCI’s Division of Cancer Prevention Frontiers in Nutrition and 
Cancer Prevention: Online CME Series. Developing CME-based courses would likely require 
partnership with the American Medical Association.  Assigning CME credits to health 
communication materials would create incentives for physicians to learn more about CAM 
therapies without being coercive. Additionally, designing an educational campaign that 
incorporates CME credit might also increase the diversity of physicians who participate in the 
program, thus further increasing awareness about the science behind CAM in addition to 
increasing the brand recognition of OCCAM.  
Another possible initiative would be to create health communication materials that 
encourage greater communication and coordination of care between primary care physicians and 
oncologists. As cancer patients enter survivorship, their interaction with their oncologist begins 
to wane, and the onus of their care shifts to their primary care physician. Survivorship care 
planning requires clear communications about the “acute and late toxicities of treatment, the 
ongoing need for cancer surveillance, non-cancer related health maintenance, and the real 
potential for disease recurrence”(p.2493).79 However, many primary care physicians lack the 
training and knowledge to treat the lingering mental, emotional, and physical symptoms of 
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cancer treatment.80,81 In addition, the roles of oncologists and primary care physicians in 
survivorship care are poorly defined.79 The Survey of Physicians’ Attitudes Regarding Care of 
Cancer Survivors, a nationally representative survey of primary care providers and oncologists’ 
knowledge and attitude about breast and colon survivorship care, revealed 40% of primary care 
physicians were confident in their ability to detect cancer recurrence, and only 23% of primary 
care physicians were confident in their the knowledge to treat the late physical effects of 
cancer.81 
Development of communication materials to help primary care physicians understand the 
possible lingering side effects of cancer treatments, such as signs of congestive heart failure, 
peripheral neuropathy, and decreased cognitive function/mental ability, may aid in the promotion 
of overall health for cancer survivors.80,81 In addition to increasing physicians’ knowledge of late 
effects of cancer treatment, these resources should seek to educate primary care physicians on 
the prevalence of CAM use among survivors and provide recommendations for CAM therapies 
explicitly for CAM survivors, as primary care physicians will play an integral role in the 
administration of healthcare to cancer survivors.  
Simultaneously, future communication initiatives should strive to reduce the stigma 
associated with CAM therapies. Many traditional physicians have a negative view of CAM, 
despite continued trends of increased popularity among the American public.21,31,40,41 For 
example, in a survey of physicians in Denver (n=302) more than 50% surveyed were not 
comfortable talking about CAM and 52% of physicians asked less than half of the time about 
CAM use.82 This same survey revealed 60% of doctors wanted to learn more about CAM in 
order engage in evidence-based conversations with their patients, with a particular interest in 
dissuading patients from use of harmful or ineffective CAM modalities.82 Some of the physician 
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pushback may be derived from a fear of the unknown: practicing physicians relative to current 
medical students may not have had the opportunity to take electives on CAM to enhance their 
formal training.31,41 A 1997 mixed method survey of 117 of the then 125 medical schools in the 
United States indicated 64% of medical schools had integrated some form of CAM course into 
their curriculum either as an elective or part of another required course.83 
One possible way OCCAM could work to reduce the stigma associated with CAM would 
be to engage in greater collaboration efforts with NCCAM. This may be particularly important 
since a recent survey of 41 NCI-designated Cancer Centers revealed 46% of their websites 
referred to NCCAM and only 12% referred to OCCAM.84 Through a collaboration, NCCAM and 
OCCAM could work to reduce some of the confusion surrounding the terminology used to 
describe CAM, i.e. “complementary medicine,” “alternative medicine,” “complementary and 
alternative medicine,” and “integrative medicine.” One healthcare provider stated, “we see a 
recurring problem with confusion about the different terminology used by OCCAM…people 
often do not know or understand the difference between ‘alternative’ and ‘integrative’ therapy” 
(NCI Public Comment, unpublished data, 2009). As the field of CAM evolves, it may become 
imperative that NCCAM and OCCAM devise a systematic definition for CAM. Many CAM 
therapies once considered “alternative” are becoming more mainstream, like acupuncture, and 
are even integrated into conventional treatment protocols, so it might be suggested the term 
CAM be replaced with “complementary medicine” or “integrative medicine.”  
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6.4 FINAL THOUGHTS 
 
Designing communication initiatives at the national level presents challenges for selecting 
images, text, format and other design elements, which will resonate with the greatest number of 
people, as well as challenges to incorporate cultural sensitivity and relevancy. However, when 
appropriately designed and tested, these campaigns can address the needs of their intended 
populations. The development and subsequent testing of OCCAM’s workbook revealed this 
initiative is important for facilitating conversations between patients and providers because no 
such resource, which asks patients to document CAM use, currently exists.  
Use of OCCAM’s workbook, whether with or independent of one’s healthcare provider, 
will serve to empower cancer patients and survivors, who in turn will be able to better articulate 
their symptoms, concerns, needs, and beliefs. Furthermore, use of this workbook may encourage 
greater information sharing between patients and healthcare providers. As patients become more 
involved in their healthcare, it will be imperative that healthcare providers help direct patients to 
reputable sources of information. Since the majority of patients report receiving their healthcare 
information online, it will be vital that physicians direct patients to .gov, .edu., or .org sites, 
instead of .com or .net sites.85 This initiative has public health significance because CAM patient 
education resources that serve to embolden patients to talk to their providers about CAM use are 
lacking, despite a continued interest in CAM among cancer patients, survivors, and the general 
public. OCCAM’s initiative is an important first step to informing, educating, and empowering 
patients to discuss complementary and alternative medicine use with their healthcare providers in 




ENVIRONMENTAL SCAN WEBSITES 
Appendix A contains the URLs for the websites included in the environmental scan. These 
websites include, but are not limited to:  
• The American Cancer Society 
• The Leukemia and Lymphoma Society  
• The Livestrong Foundation 
• Susan G. Komen for the Cure 
This appendix includes the general website URLs as well as specific URLs for the patient 











Alliance of State Pain Initiatives: www.trc.wisc.edu 
American Cancer Society: www.cancer.org 
Breast Cancer Action: www.bcaction.org 
BreastCancer.org: www.breastcancer.org 
The CancerJourney.org: www.thecancerjourney.org 
Colon Cancer Alliance: www.ccalliance.org 
Dana Farber Cancer Institute: www.dana-farber.org 
Hirshberg Foundation for Pancreatic Cancer: www.pancreatic.org 
Leukemia and Lymphoma Society: www.lls.org 
Livestrong Foundation: www.livestrong.org 
Lung Cancer Alliance: www.lungcanceralliance.org 
MD Anderson Cancer Center: www.mdanderson.org 
Memorial Sloan-Kettering Cancer Center: www.mskcc.org 
National Brain Tumor Foundation: www.braintumor.org 
National Cancer Institute: www.cancer.gov 
National Center for Complementary and Alternative Medicine: www.nccam.nih.gov 
National Ovarian Cancer Coalition: www.ovarian.org 
National Patient Safety Foundation: www.npsf.org 
Patients Advocates for the Advanced Cancer Treatment: www.paactusa.org 
Patients Against Lymphoma: www.lymphomation.org 
Prostate Cancer Foundation: www.pcf.org 
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ProstateNet.org: www.prostatenet.org 
Susan G. Komen for the Cure: www.komen.org 













OPEN CALL TESTING INFORMATION 
Appendix B contains the versions of the patient education workbook pages, which were tested 
during Open Call Testing. These pages include:  
• Versions 1 and 2 of Why I want to use CAM 
• Versions 1 and 2 of My Weekly CAM use  
• Versions 1 and 2 of the cover 
Appendix B also contains the screening questions used to recruit participants for Open Call 
Testing, OCCAM’s list of questions to be addressed during Open Call Testing, the finalized 
moderator’s guide, which was used during Open Call Testing, and the feedback tracking forms 








B.1.1 Screening Questions  
1. Have you engaged in any of the following activities? Check all that apply.  
a. Yoga 
b. Meditation 




g. Chiropractic Care 
h. Following specific diet plan 
i. Exercise 
j. Taken dietary supplements (including vitamins or herbal and plant-based 
products) 
 

























B.1.2 OCCAM’s list of questions for pretesting  
Open Call Testing Items to Test: 
Specific Items to Test with Alternative Versions 
(MG)  = questions included on the Moderator’s Guide  
Title Page:  
• (MG) Alternative Titles 
• (MG) Word Usage, i.e. guide vs. workbook 
• (MG) Pictures 
• (MG) Color palettes 
• (MG) Size of OCCAM’s banner 
 
Understanding cancer CAM interests 
• (MG) Would you use this form? Why or Why not? 
• Why do you think this form would be helpful, or why not? 
• Would this form help you to organize your thoughts about CAM use?  
• (MG) Would this form help you to discuss with your doctor your use of CAM therapies?  
• (MG) Layout of pictures:  Which format do you prefer?  Why?  
• (MG) Pictures 
• Are the directions clear? 
• (MG) Orientation of text boxes 
• Is there enough space to write answers to questions regarding CAM use? 
• (MG) If you could add one question to this page, what would it be? 
 
Weekly CAM therapy use 
• Would you track the use of CAM therapies?  
• Are the examples clear?  
• (MG) Is the conventional therapy space at the top of the page helpful?  
o Would you want to track your conventional therapies at all on this form or would 
you prefer to track conventional therapies on a completely separate form?  
• Days of the week listed vs. blank spaces to be filled in by user 
• Line weight:  thick lines vs. dashed 
• Line spacing: is there enough space to write on this form?  
• (MG) Would you show this page to your doctor and discuss your weekly CAM use with 
your healthcare team? 
• Would this page facilitate/ make it easier to talk to your doctor about your use of CAM 
therapies?  
 96 
• What type of information do you think should go in the last column?  
• (MG) Would you suggest changing any of the column titles? Are there other 
titles/headings that would be more useful? 
 
General Items to Test  
• (MG) Is this helpful? Would you find this helpful/useful/ beneficial?  
• Worth/Usability 
• Have you ever used something like this before?  
• Do these worksheets help formulate your thoughts?  
• Are the headings clear? Do the headings make sense to you? If not, what would you 
suggest? 
• Throughout the workbook are the directions clear?  
• Other ideas from patients, what’s missing from this workbook?  
• What is confusing to you?  
• What does this mean to you?  
• What would you put down?  
• Font size 
• Color scheme 
• Other recommendations for the workbook 
• If your doctor gave you this workbook, would that make you motivated to complete it? 
• Would you rather print out the entire workbook or specific pages? Which pages would 
you be most likely to print out?  
• (MG) Would you prefer to fill out these forms online or to print them out and fill in the 
information by hand?  
 
 
Shea’s Suggestions:  
• (MG) Would this be something you would use?  Would you be more likely to print it off 
and fill it out or fill it in online? 
• (MG) What changes would you recommend? 
• What do you expect this to contain based on the title?  What does the word tool mean to 
you?  Are there alternate titles that you would recommend based on the contents? 
• Are the instructions clear on this page?  Is there adequate space for you within the 
charts?  Are there enough spaces for you to fill in all of your healthcare 
providers/medications/CAM therapies?   
• How would you make this chart better?   
• Does the order of the sheets make sense to you? 
• How would you use these?   
• Do you prefer this wording or this wording?  Images?  Format?   













B.1.4 Draft Versions Tested  
 




























Figure 6. Version B of the workbook cover 
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B.1.5 Healthcare Provider Feedback Tracking Form  
Healthcare Provider Feedback Form 
Federal Employee/ Contractor (circle one)   Occupation:  _______________________ 
 
1. Would you find a resource useful that encourages conversations with your patients about their CAM use and 
beliefs?  
 
2. Based on your clinical experience, do you think this would be a resource patients would use?  
 
3. Would you recommend a resource such as this to a cancer patient? 
 
4. Identify who you would think is most likely to use this resource in the clinical setting?  Are there multiple people? 
 
5. Would patients keeping track of their CAM use in these logs help you enhance their care?  
 
6. Describe changes you would suggest to make the resource more useful in your practice?  
 











Understanding cancer CAM terminology  
 
Why I want to use CAM 
 
 
Tips for talking with your provider 
 
 
My Weekly CAM log  
 
 
My Complete Medication List 
 










Appendix C consists of three tables (Tables 1-3) that describe the individuals who were surveyed 
during OCCAM’s pretesting effort. Table 1 illustrates the varied backgrounds of the cancer 
survivors who participated in Open Call Testing, while Table 2 shows the number of cancer 
survivors, healthcare providers, cancer advocates, and caregivers who were surveyed in each 
round of testing. Finally, Table 3 differentiates between federal and non-federal healthcare 
















Sex Age Race Education Cancer Type Year of 
Diagnosis 
Female 24 Caucasian College Degree Leukemia 2010 
Male 25 African American College Degree Hodgkin’s Lymphoma 2010 
Male 42 African American High School Kidney Cancer 2011 
Female  57 Caucasian-Hispanic College Degree Breast Cancer 2010 
Female 58 Caucasian Some College Breast Cancer 2010 
Male 63 African American Some College Prostate Cancer 2011 
Female  65 Caucasian-Hispanic College Degree,  Some Graduate Breast Cancer 2010 
Female 71 Caucasian-Hispanic College Degree Breast Cancer 2007 
Female 74 Caucasian Some College 
Colon Cancer,  
Bladder Cancer,  
Melanoma, Sarcoma 
2012 
Table 1. Open Call Testing Participant Demographics 






Survivor 9 1 9 
Survivor 3 2 3 
Healthcare Provider, Caregiver, or Advocate 15 1 15 
Healthcare Provider, Caregiver, or Advocate 15 2 15 
Total  42 
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*At the American Society of Clinical Oncologist’s Annual Meeting four of six physicians 
provided voluntary comments, and the remaining two physicians were contacted during the first 







Healthcare Professional Number Surveyed Federal or Non-Federal Affiliation Total 
Physician (M.D. or D.O.) 2 Federal 2 
Physician (M.D. or D.O.)   6* Non-Federal   6* 
Nurse Practitioner (N.P) 3 Federal 3 
Nurse Practitioner (N.P.) 2 Non-Federal 2 
Nurse (R.N) 5 Federal 5 
Social Worker (S.W). 1 Federal 1 
Registered Dietitian (R.D) 1 Non-Federal 1 
Total Healthcare Providers 20 
Table 3. Distribution and Type of Healthcare Provider Surveyed 
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APPENDIX D 
TALKING ABOUT COMPLEMENTARY AND ALTERNATIVE MEDICINE WITH 
HEALTH CARE PROVIDERS: A WORKBOOK AND TIPS 
Appendix D consists of screenshot of final versions of each page included within the patient 
education booklet, Talking about Complementary and Alternative Medicine with Health Care 
Providers: A Workbook and Tips. The workbook pages have been included to provide the reader 
with a sample of the health communication material created for the Office of Cancer 
Complementary and Alternative Medicine of the National Cancer Institute. The workbook may 






























































Appendix E contains screenshots of OCCAM’s promotion of Talking about Complementary and 
Alternative Medicine with Health Care Providers: A Workbook and Tips via OCCAM’s website, 































Figure 11. NCI promotion of OCCAM's workbook via Facebook 
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Figure 13. AOSW Facebook share of OCCAM's workbook 
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